The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door |
J Rheumatol. 2021 Jun 1;jrheum.210224. doi: 10.3899/jrheum.210224.Online ahead of print. |
| 2 | |
Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom |
Rheumatology (Oxford). 2021 Jun 3;keab464. doi: 10.1093/rheumatology/keab464.Online ahead of print. Peter C Taylor 1, Matthew Woods 2, Catherine Rycroft 2, Priya Patel 3, Sophee Blanthorn-Hazell 3, Toby Kent 3, Marwan Bukhari 4 |
| 3 | |
What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction? |
ACR Open Rheumatol. 2021 Jul;3(7):457-463. doi: 10.1002/acr2.11266. Epub 2021 Jun 4. Helga Westerlind 1, Mateusz Maciejewski 2, Thomas Frisell 1, Scott A Jelinsky 2, Daniel Ziemek 2, Johan Askling 1 |
| 6 | |
Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests |
J Rheumatol. 2021 May 15;jrheum.201510. doi: 10.3899/jrheum.201510.Online ahead of print. Johannes W G Jacobs 1, Maxime M A Verhoeven 1, Paco M J Welsing 1 |
| 7 | |
Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis |
J Rheumatol. 2021 May 15;jrheum.201439. doi: 10.3899/jrheum.201439. Online ahead of print. Sanketh Rampes 1, Vishit Patel 1, Ailsa Bosworth 1, Clare Jacklin 1, Deepak Nagra 1, Mark Yates 1, Sam Norton 1, James Galloway 1 |
| 8 | |
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis |
Front Immunol. 2021 Apr 29;12:673916. doi: 10.3389/fimmu.2021.673916.eCollection 2021. Sally A Clayton 1 2, Lucy MacDonald 3 4, Mariola Kurowska-Stolarska 3 4, Andrew R Clark 1 2 |
| 9 | |
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis |
Ann Rheum Dis. 2021 May 28;annrheumdis-2021-220125.doi: 10.1136/annrheumdis-2021-220125. Online ahead of print. Tate M Johnson 1 2, Harlan R Sayles 1 3, Joshua F Baker 4 5, Michael D George 4 5, Punyasha Roul 1, Cheng Zheng 3, Brian Sauer 6 7, Katherine P Liao 8, Daniel R Anderson 9, Ted R Mikuls 1 2, Bryant R England 10 2 |
| 10 | |
Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning |
J Rheumatol. 2021 May 1;jrheum.201626. doi: 10.3899/jrheum.201626. Online ahead of print. Fredrik D Johansson 1, Jamie E Collins 1, Vincent Yau 1, Hongshu Guan 1, Seoyoung C Kim 1, Elena Losina 1, David Sontag 1, Jacklyn Stratton 1, Huong Trinh 1, Jeffrey Greenberg 1, Daniel H Solomon 1 |
| 11 | |
The utility of therapeutic plasma exchange in Hyperviscosity syndrome associated with juvenile rheumatoid arthritis: A case report |
J Clin Apher. 2021 May 4. doi: 10.1002/jca.21903. Online ahead of print. Allen P Green 1, Adam C Gonzalez 2, Jack B Alperin 3, James D Burner 1, Sean G Yates 1 |
| 12 | |
Clinical use of Jak 1 inhibitors for rheumatoid arthritis |
Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii31-ii38.doi: 10.1093/rheumatology/keab265. |
| 13 | |
Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis |
Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii17-ii23.doi: 10.1093/rheumatology/keaa823. |
| 14 | |
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort |
Int Immunopharmacol. 2021 Apr 29;97:107719. doi: 10.1016/j.intimp.2021.107719.Online ahead of print. Bryant R England 1, Megan Campany 2, Harlan Sayles 2, Punyasha Roul 2, Yangyuna Yang 2, Apar Kishor Ganti 3, Jeremy Sokolove 4, William H Robinson 5, Andreas M Reimold 6, Gail S Kerr 7, Grant W Cannon 8, Brian C Sauer 8, Joshua F Baker 9, Geoffrey M Thiele 10, Ted R Mikuls 10 |
| 15 | |
Identification and Evaluation of Serum Protein Biomarkers Which Differentiate Psoriatic from Rheumatoid Arthritis |
Arthritis Rheumatol. 2021 Jun 11. doi: 10.1002/art.41899. Online ahead of print. Angela Mc Ardle 1, Anna Kwasnik 1, Agnes Szenpetery 1, Belinda Hernandez 2 3, Andrew Parnell 3, Wilco de Jager 4 5, Sytze de Roock 5, Oliver FitzGerald 1, Stephen R Pennington 1 |
| 16 | |
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study |
Medicine (Baltimore). 2021 Apr 30;100(17):e25481. doi: 10.1097/MD.0000000000025481. Alberto Floris 1, Daniela Perra 1, Ignazio Cangemi 1, Mattia Congia 1, Elisabetta Chessa 1, Maria Maddalena Angioni 1, Arduino Aleksander Mangoni 2, Gian Luca Erre 3, Alessandro Mathieu 1, Matteo Piga 1, Alberto Cauli 3 |
| 17 | |
Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case-control study |
Rheumatology (Oxford). 2021 Apr 26;keab388. doi: 10.1093/rheumatology/keab388.Online ahead of print. Toby O Smith 1 2, Celia Clarke 1, Jack R Dainty 1, Laura Watts 1, Max Yates 1 3, Valerie M Pomeroy 1 4, Emma Stanmore 5, Terence W O'Neill Tw 6, Alexander J Macgregor 1 3 |
| 18 | |
Perioperative Management of Antirheumatic Medications in Patients with RA and SLE Undergoing Elective Foot and Ankle Surgery: A Critical Analysis Review |
JBJS Rev. 2021 Jun 8;9(6). doi: 10.2106/JBJS.RVW.20.00201. Noah E Saunders 1, James R Holmes 2, David M Walton 2, Paul G Talusan 3 |
| 19 | |
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift) |
RMD Open. 2021 Jun;7(2):e001673. doi: 10.1136/rmdopen-2021-001673. Stanley B Cohen 1, Janet Pope 2, Boulos Haraoui 3, Eduardo Mysler 4, Annette Diehl 5, Tatjana Lukic 6, Shixue Liu 7, Lori Stockert 5, Rebecca Germino 6, Sujatha Menon 8, Harry Shi 6, Edward C Keystone 9 |
| 20 | |
Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors |
Rheumatology (Oxford). 2021 Apr 19;keab355. doi: 10.1093/rheumatology/keab355.Online ahead of print. Roy Fleischmann 1, Mark C Genovese 2, Karina Maslova 3, Henry Leher 4, Amy Praestgaard 5, Gerd R Burmester 6 |
| 21 | |
Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial |
RMD Open. 2021 Apr;7(1):e001627. doi: 10.1136/rmdopen-2021-001627. Juliana Rachel Hoeper 1 2, Jan Zeidler 1, Sara Eileen Meyer 2, Georg Gauler 3, Patricia Steffens-Korbanka 3, Martin Welcker 4, Jörg Wendler 5, Florian Schuch 5, Ulrich von Hinüber 6, Andreas Schwarting 7 8, Torsten Witte 2, Dirk Meyer-Olson 2 9, Kirsten Hoeper 10 |
| 22 | |
Demyelinating Events Following Initiation of Anti-TNFa Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis |
Neurol Neuroimmunol Neuroinflamm. 2021 Apr 16;8(3):e992.doi: 10.1212/NXI.0000000000000992. Print 2021 May. Thomas R P Taylor 1, James Galloway 1, Rebecca Davies 1, Kimme Hyrich 1, Ruth Dobson 2 |
| 23 | |
Epstein-Barr virus -related lymphoma in rheumatoid arthritis: Implications for long-term usage of immunosuppressive drugs and review of the literature |
Intern Med J. 2021 May 24. doi: 10.1111/imj.15390. Online ahead of print. Jianna He 1, Luke Williamson 1, Ken Cai 1, Peter Wong 1 2, Allan Sturgess 3, John Taper 4, Nicholas Manolios 1 5 |
| 24 | |
Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study |
Rheumatol Ther. 2021 May 24. doi: 10.1007/s40744-021-00317-9. Online ahead of print. Alvin F Wells 1, Bochao Jia 2, Li Xie 2, Guillermo J Valenzuela 3, Edward C Keystone 4, Zhanguo Li 5, Amanda K Quebe 6, Kirstin Griffing 2, Susan Otawa 2, Boulos Haraoui 7 |
| 25 | |
Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured? |
Arthritis Rheumatol. 2021 May 13. doi: 10.1002/art.41801. Online ahead of print. |
| 26 | |
Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-Based Network |
Arthritis Care Res (Hoboken). 2021 May 10. doi: 10.1002/acr.24626. Online ahead of print. Michael George 1, Maria I Danila 2, Daniel Watrous 3, Shanmugapriya Reddy 4, Jeffrey Alper 5, Fenglong Xie 2, W Benjamin Nowell 6, Joel Kallich 7, Cassie Clinton 2, Kenneth G Saag 2, Jeffrey R Curtis 2 |
| 27 | |
Meaningful change thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue and pain interference scores in patients with rheumatoid arthritis |
J Rheumatol. 2021 Mar 15;jrheum.200990. doi: 10.3899/jrheum.200990. Online ahead of print. Jennifer L Beaumont 1, Elizabeth S Davis 1, James F Fries 1, Jeffrey R Curtis 1, David Cella 1, Huifeng Yun 1 |
| 28 | |
Role of Janus Kinase inhibitors in rheumatoid arthritis treatment |
Curr Opin Rheumatol. 2021 May 1;33(3):300-306. doi: 10.1097/BOR.0000000000000792. |
| 29 | |
Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials |
Rheumatol Ther. 2021 Apr 2. doi: 10.1007/s40744-021-00302-2. Online ahead of print. Catherine B McGuiness 1, Natalie N Boytsov 2, Xiang Zhang 2, Xin Wang 3, Carol L Kannowski 2, Rolin L Wade 3 |
| 30 | |
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry |
Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25. Dimitrios A Pappas 1, Taylor Blachley 2, Jennie H Best 3, Steve Zlotnick 3, William G Reiss 3, Kelechi Emeanuru 2, Joel M Kremer 2 4 |
| 31 | |
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease |
Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020. Livia Savarese 1, Maria Francesca Freda 1, Raffaele De Luca Picione 2, Pasqaule Dolce 3, Raffaella De Falco 4, Maria Alessio 5, Mauro Cancian 6, Adriana Franzese 5, Maria Domenica Guarino 7, Roberto Perricone 7, Angelica Petraroli 8, Riccardo Senter 1, Claudia Traverso 5, Andrea Zanichelli 9, Eugenio Zito 10, Maria Bova 5 |
| 32 | |
Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups |
J Clin Med. 2021 Apr 1;10(7):1403. doi: 10.3390/jcm10071403. |
| 33 | |
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry |
Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25. Dimitrios A Pappas 1, Taylor Blachley 2, Jennie H Best 3, Steve Zlotnick 3, William G Reiss 3, Kelechi Emeanuru 2, Joel M Kremer 2 4 |
| 34 | |
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease |
Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020. Livia Savarese 1, Maria Francesca Freda 1, Raffaele De Luca Picione 2, Pasqaule Dolce 3, Raffaella De Falco 4, Maria Alessio 5, Mauro Cancian 6, Adriana Franzese 5, Maria Domenica Guarino 7, Roberto Perricone 7, Angelica Petraroli 8, Riccardo Senter 1, Claudia Traverso 5, Andrea Zanichelli 9, Eugenio Zito 10, Maria Bova 5 |
| 35 | |
Discrepancy Between Multi-Biomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2021 Feb 28. doi: 10.1002/acr.24583. Online ahead of print. Roy Fleischmann 1, Jingyu Liu 2, Julie Zhu 2, Oscar G Segurado 3, Daniel E Furst 4 |
| 36 | |
The association between increased body mass index and response to conventional synthetic DMARD treatment in rheumatoid arthritis: Results from the METEOR database |
Rheumatology (Oxford). 2021 Apr 30;keab389. doi: 10.1093/rheumatology/keab389.Online ahead of print. Mrinalini Dey 1 2, Sizheng S Zhao 1 2, Robert J Moots 2 3, Sytske Anne Bergstra 4, Robert B Landewe 5 6, Nicola J Goodson 2 |
| 37 | |
Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial |
ACR Open Rheumatol. 2021 May 1. doi: 10.1002/acr2.11256. Online ahead of print. Jon T Giles 1, Pamela M Rist 2, Katherine P Liao 2, Ahmed Tawakol 3, Zahi A Fayad 4, Venkatesh Mani 4, Nina P Paynter 2, Paul M Ridker 2, Robert J Glynn 2, Fengxin Lu 5, Rachel Broderick 1, Meredith Murray 5, Kathleen M M Vanni 5, Daniel H Solomon 2, Joan M Bathon 1 |
| 38 | |
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic |
Expert Rev Clin Immunol. 2021 Apr 14;1-11. doi: 10.1080/1744666X.2021.1908887.Online ahead of print. Ennio Giulio Favalli 1, Gabriella Maioli 1, Martina Biggioggero 1, Roberto Caporali 1 2 |
| 39 | |
Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study |
Patient Prefer Adherence. 2021 Feb 17;15:359-373. doi: 10.2147/PPA.S289692. eCollection 2021. Peter C Taylor 1, Codrina Ancuta 2, Orsolya Nagy 3, María C de la Vega 4, Andrey Gordeev 5, Radka Janková 6, Umut Kalyoncu 7, Ivan Lagunes-Galindo 3, Jadranka Morovic-Vergles 8, Mariana Peixoto G U E Silva de Souza 9, Bernadette Rojkovich 10, Prodromos Sidiropoulos 11, Atsushi Kawakami 12 |
| 40 | |
Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof |
J Med Chem. 2021 Feb 25;64(4):2228-2241. doi: 10.1021/acs.jmedchem.0c01952.Epub 2021 Feb 11. Ryan R Davis 1, Baoli Li 1, Sang Y Yun 2, Alice Chan 1, Pradeep Nareddy 1, Steven Gunawan 1, Muhammad Ayaz 2, Harshani R Lawrence 2, Gary W Reuther 3, Nicholas J Lawrence 1, Ernst Schönbrunn 1 |
| 41 | |
Managing Cardiovascular Risk in Patients with Rheumatic Disease |
Med Clin North Am. 2021 Mar;105(2):247-262. doi: 10.1016/j.mcna.2020.09.010.Epub 2021 Jan 14. |
| 42 | |
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights |
Expert Rev Clin Pharmacol. 2021 Apr 13;1-10. doi: 10.1080/17512433.2021.1913050.Online ahead of print. Maria Gabriella Raimondo 1, Martina Biggioggero 2, Lavinia Agra Coletto 3, Andreas Ramming 1, Roberto Caporali 2 3, Ennio Giulio Favalli 2 |
| 43 | |
Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail! |
Arthritis Rheumatol. 2021 Mar 28. doi: 10.1002/art.41746. Online ahead of print. |
| 44 | |
Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study |
Osteoporos Int. 2021 Feb 11. doi: 10.1007/s00198-021-05862-1. Online ahead of print. |
| 45 | |
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry |
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871.Epub 2020 May 29. Milena Gianfrancesco # 1, Kimme L Hyrich # 2 3, Sarah Al-Adely 2 3, Loreto Carmona 4, Maria I Danila 5, Laure Gossec 6 7, Zara Izadi 1, Lindsay Jacobsohn 1, Patricia Katz 1, Saskia Lawson-Tovey 3 8, Elsa F Mateus 9, Stephanie Rush 1, Gabriela Schmajuk 1, Julia Simard 10, Anja Strangfeld 11, Laura Trupin 1, Katherine D Wysham 12, Suleman Bhana 13, Wendy Costello 14, Rebecca Grainger 15, Jonathan S Hausmann 16 17, Jean W Liew 12, Emily Sirotich 18 19, Paul Sufka 20, Zachary S Wallace 17 21, Jinoos Yazdany # 1, Pedro M Machado # 22 23 24, Philip C Robinson # 25 26, COVID-19 Global Rheumatology Alliance |
| 46 | |
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry |
ACR Open Rheumatol. 2021 Mar;3(3):173-184. doi: 10.1002/acr2.11232. Epub 2021 Feb 11. Joel M Kremer 1, Clifton O Bingham 3rd 2, Laura C Cappelli 2, Jeffrey D Greenberg 3, Ann M Madsen 4, Jamie Geier 4, Jose L Rivas 5, Alina M Onofrei 6, Christine J Barr 6, Dimitrios A Pappas 7, Heather J Litman 6, Kimberly J Dandreo 6, Andrea B Shapiro 8, Carol A Connell 9, Arthur Kavanaugh 10 |
| 47 | |
The Online Sharing of Instagram Images for Rheumatoid Arthritis |
Comput Inform Nurs. 2020 Jul 24;39(2):89-96. doi: 10.1097/CIN.0000000000000660. |
| 48 | |
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review |
J Clin Med. 2021 Feb 1;10(3):509. doi: 10.3390/jcm10030509. Peter C Taylor 1, Fabiola Atzeni 2, Alejandro Balsa 3, Laure Gossec 4 5, Ulf Müller-Ladner 6, Janet Pope 7 |
| 49 | |
Peripheral Ulcerative Keratitis in Rheumatoid Arthritis Patients Taking Tocilizumab: Paradoxical Manifestation or Insufficient Efficacy? |
Rheumatology (Oxford). 2021 Feb 2;keab093. doi: 10.1093/rheumatology/keab093.Online ahead of print. Florian Cohen 1, Eric Ernest Gabison 2, Sophie Stéphan 2, Rakiba Belkhir 3, Gaetane Nocturne 3 4, Anne-Laurence Best 1, Oscar Haigh 4, Emmanuel Barreau 1, Marc Labetoulle 1 4, Raphaele Seror 3, Antoine Rousseau 1 4 |
| 50 | |
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program |
Drug Saf. 2021 Feb 2. doi: 10.1007/s40264-020-01036-w. Online ahead of print. Philip G Conaghan 1, Eduardo Mysler 2, Yoshiya Tanaka 3, Barbara Da Silva-Tillmann 4, Tim Shaw 5, John Liu 4, Ryan Ferguson 4, Jeffrey V Enejosa 4, Stanley Cohen 6, Peter Nash 7, William Rigby 8, Gerd Burmester 9 |
| 51 | |
Location, location, location: how the tissue microenvironment affects inflammation in RA |
Nat Rev Rheumatol. 2021 Feb 1. doi: 10.1038/s41584-020-00570-2.Online ahead of print. Christopher D Buckley 1 2, Caroline Ospelt 3, Steffen Gay 3, Kim S Midwood 4 |
| 52 | |
Safety and Efficacy of Filgotinib: Up to 4-Year Results From an Open-Label Extension Study of Phase 2 Rheumatoid Arthritis Programs |
J Rheumatol. 2021 Feb 1;jrheum.201183. doi: 10.3899/jrheum.201183. Online ahead of print. Arthur Kavanaugh 1, Rene R Westhovens 1, Kevin L Winthrop 1, Susan J Lee 1, YingMeei Tan 1, Di An 1, Lei Ye 1, John S Sundy 1, Robin Besuyen 1, Luc Meuleners 1, Mykola Stanislavchuk 1, Alberto J Spindler 1, Maria Greenwald 1, Rieke Alten 1, Mark C Genovese 1
|
| 53 | |
Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US |
Rheumatol Ther. 2021 Jan 23. doi: 10.1007/s40744-020-00275-8. Online ahead of print. Alison Walton 1, Jim Paik 2, Amanda Quebe 2, Carol L Kannowski 2, Casey Choong 2, Seth Anderson 2, Justin K Owensby 3 |
| 55 | |
Corticosteroids: Review of the History, the Effectiveness, and Adverse Effects in the Treatment of Joint Pain |
Pain Physician. 2021 Jan;24(S1):S233-S246. |
| 56 | |
Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis |
Rheumatology (Oxford). 2021 Jan 25;keab029. doi: 10.1093/rheumatology/keab029.Online ahead of print. Ciara M O'Brien 1 2, Nikos Ntoumanis 3, Joan L Duda 1, George D Kitas 2, Jet J C S Veldhuijzen van Zanten 1 2, George S Metsios 2 4, Sally A M Fenton 1 2 |
| 57 | |
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review |
Rheumatol Int. 2021 Jan 29. doi: 10.1007/s00296-020-04773-4. Online ahead of print. Julie K Dawson 1, Edmond Quah 2, Ben Earnshaw 2, Constanta Amoasii 2, Tareg Mudawi 2, Lisa G Spencer 3 |
| 58 | |
Erectile Dysfunction and Cardiovascular Risk in Men with Rheumatoid Arthritis: A Population- Based Cohort Study |
J Rheumatol. 2021 Jan 15;jrheum.201226. doi: 10.3899/jrheum.201226. Online ahead of print. Katelynn M Wilton 1, Sara J Achenbach 1, John M Davis 3rd 1, Elena Myasoedova 1, Eric L Matteson 1, Cynthia S Crowson 1 |
| 59 | |
Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada |
J Rheumatol. 2020 Sep 1;jrheum.200688. doi: 10.3899/jrheum.200688. Online ahead of print. Claire E H Barber 1, Karen L Then 1, Victoria Bohm 1, Marc Hall 1, Deborah A Marshall 1, James A Rankin 1, Cheryl Barnabe 1, Glen S Hazlewood 1, Linda C Li 1, Dianne Mosher 1, Joanne Homik 1, Paul MacMullan 1, Karen Tsui 1, Kelly English 1, Diane Lacaille, RA Quality Measurement Delphi Panel Group |
| 60 | |
Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial |
Ann Rheum Dis. 2021 Jan 15;annrheumdis-2020-219213.doi: 10.1136/annrheumdis-2020-219213. Online ahead of print. René Westhovens 1 2, William F C Rigby 3, Désirée van der Heijde 4, Daniel W T Ching 5, William Stohl 6, Jonathan Kay 7 8, Arvind Chopra 9, Beatrix Bartok 10, Franziska Matzkies 10, Zhaoyu Yin 10, Ying Guo 10, Chantal Tasset 11, John S Sundy 10 12, Angelika Jahreis 10, Neelufar Mozaffarian 13, Osvaldo Daniel Messina 14 15, Robert Bm Landewé 16 17, Tatsuya Atsumi 18, Gerd R Burmester 19 20 |
| 61 | |
Is gene expression among women with rheumatoid arthritis dysregulated during a postpartum flare? |
Arthritis Res Ther. 2021 Jan 18;23(1):30. doi: 10.1186/s13075-021-02418-w. Matthew Wright 1, Mette K Smed 2, J Lee Nelson 3 4, Jørn Olsen 5 6, Merete L Hetland 7 8, Vibeke Zoffmann 2 9, Damini Jawaheer 10 11 |
| 62 | |
Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients |
Rheumatology (Oxford). 2021 Jan 18;keaa836. doi: 10.1093/rheumatology/keaa836.Online ahead of print. Jeffrey A Sparks 1 2, Yinzhu Jin 3, Soo-Kyung Cho 4, Seanna Vine 3, Rishi Desai 2 3, Tracy J Doyle 2 5, Seoyoung C Kim 1 2 3 |
| 63 | |
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab |
Biologics. 2021 Jan 6;15:1-15. doi: 10.2147/BTT.S285610. eCollection 2021. Timothy Fitzgerald 1, Richard Melsheimer 2, Marie-Hélène Lafeuille 3, Patrick Lefebvre 3, Laura Morrison 3, Kimberly Woodruff 1, Iris Lin 1, Bruno Emond 3 |
| 64 | |
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis |
Rheumatology (Oxford). 2021 Jan 12;keaa834. doi: 10.1093/rheumatology/keaa834.Online ahead of print. Andrew R Melville 1 2, Md Yuzaiful Md Yusof 1 2, John Fitton 1 2, Leticia Garcia-Montoya 1 2, Lynda Bailey 3, Shouvik Dass 1 2, Paul Emery 1 2, Maya H Buch 1 4, Benazir Saleem 3 |
| 65 | |
Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data |
Arthritis Res Ther. 2021 Jan 11;23(1):17. doi: 10.1186/s13075-020-02399-2. |
| 66 | |
Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis |
BMC Musculoskelet Disord. 2021 Jan 8;22(1):47. doi: 10.1186/s12891-020-03917-8. Alison Hammond 1, Yeliz Prior 2, Sarah Cotterill 3, Chris Sutton 3, Elizabeth Camacho 4, Calvin Heal 3, Jo Adams 5, Yvonne Hough 6, Terence W O'Neill 7 8, Jill Firth 9 |
| 67 | |
Thoracic Manifestations of Rheumatoid Arthritis |
Radiographics. Jan-Feb 2021;41(1):32-55. doi: 10.1148/rg.2021200091. Lauren K Groner 1, Daniel B Green 1, Stacey V Weisman 1, Alan C Legasto 1, Dennis Toy 1, James F Gruden 1, Joanna G Escalon 1 |
| 68 | |
Current Management of Trigger Digit in Rheumatoid Arthritis Patients: A Survey of ASSH Members |
Hand (N Y). 2020 Dec 29;1558944720975137. doi: 10.1177/1558944720975137.Online ahead of print. Rebecca Bickham 1, Logan Carr 2, James Butterfield 1, Brittany Behar 3, Ann-Marie Dyer 1, Alexander Payatakes 1 |
| 69 | |
Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses |
BMJ Open. 2020 Dec 31;10(12):e041420. doi: 10.1136/bmjopen-2020-041420. Carlos Alves 1 2, Ana Penedones 2, Diogo Mendes 2, Francisco Batel-Marques 3 2 |
| 70 | |
Statins and lower mortality in rheumatic diseases: An effect of immortal time bias? |
Semin Arthritis Rheum. 2020 Dec 19;51(1):211-218.doi: 10.1016/j.semarthrit.2020.11.010. Online ahead of print. Devin Abrahami 1, Marie Hudson 2, Samy Suissa 3 |
| 71 | |
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities |
Semin Arthritis Rheum. 2020 Dec 17;51(1):219-229.doi: 10.1016/j.semarthrit.2020.11.005. Online ahead of print. Janet E Pope 1, Ernest H Choy 2 |
| 72 | |
The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT |
Rheumatol Int. 2021 Jan 2. doi: 10.1007/s00296-020-04760-9. Online ahead of print. Sean G McKenna 1 2, Alan Donnelly 3 4, Bente Appel Esbensen 5 6, Laura Comber 7, Wan Lin Ng 8, Aqeel Maqsoon Anjum 8, Alexander Fraser 8, Norelee M Kennedy 7 4 |
| 73 | |
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study |
Rheumatology (Oxford). 2020 Dec 25;keaa771. doi: 10.1093/rheumatology/keaa771.Online ahead of print. Jennifer C E Lane 1, James Weaver 2, Kristin Kostka 3, Talita Duarte-Salles 4, Maria Tereza F Abrahao 5, Heba Alghoul 6, Osaid Alser 7, Thamir M Alshammari 8, Carlos Areia 9, Patricia Biedermann 10, Juan M Banda 11, Edward Burn 1 4, Paula Casajust 12, Kristina Fister 13, Jill Hardin 2, Laura Hester 2, George Hripcsak 14 15, Benjamin Skov Kaas-Hansen 16 17, Sajan Khosla 18, Spyros Kolovos 1, Kristine E Lynch 19 20, Rupa Makadia 2, Paras P Mehta 21, Daniel R Morales 22, Henry Morgan-Stewart 3, Mees Mosseveld 23, Danielle Newby 24, Fredrik Nyberg 25, Anna Ostropolets 14, Rae Woong Park 26, Albert Prats-Uribe 1, Gowtham A Rao 2, Christian Reich 3, Peter Rijnbeek 23, Anthony G Sena 2 23, Azza Shoaibi 2, Matthew Spotnitz 14, Subbian Vignesh 27, Marc A Suchard 28, David Vizcaya 29, Haini Wen 30, Marcel de Wilde 23, Junqing Xie 1, Seng Chan You 26, Lin Zhang 31 32, Simon Lovestone 33, Patrick Ryan 2 14, Daniel Prieto-Alhambra 1, OHDSI-COVID-19 consortium |
| 74 | |
Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis |
Int Immunopharmacol. 2020 Dec 23;91:107260. doi: 10.1016/j.intimp.2020.107260.Online ahead of print. Alison D Petro 1, Joseph Dougherty 2, Bryant R England 3, Harlan Sayles 4, Michael J Duryee 5, Carlos D Hunter 6, Joel M Kremer 7, Dimitrios A Pappas 8, William H Robinson 9, Jeffrey R Curtis 10, Geoffrey M Thiele 11, Ted R Mikuls 12 |
| 75 | |
The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis |
Semin Arthritis Rheum. 2020 Dec 17;51(1):15-19.doi: 10.1016/j.semarthrit.2020.09.016. Online ahead of print. Doyt L Conn 1 |
| 76 | |
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease |
Rheumatology (Oxford). 2020 Dec 17;keaa860. doi: 10.1093/rheumatology/keaa860.Online ahead of print. Nadia M T Roodenrijs 1, Marlies C van der Goes 1 2, Paco M J Welsing 1, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1 |
| 77 | |
Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway |
Rheumatology (Oxford)2020 Dec 17;keaa858. doi: 10.1093/rheumatology/keaa858.Online ahead of print. John Fitton 1 2, Andrew R Melville 1 2, Paul Emery 1 2, Jacqueline L Nam 1 2, Maya H Buch 1 3 |
| 78 | |
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience |
Clin Exp Rheumatol. 2020 Dec 18. Online ahead of print. Francesca Romana Spinelli 1, Fulvia Ceccarelli 2, Cristina Garufi 2, Ilaria Duca 2, Silvia Mancuso 2, Enrica Cipriano 2, Elisabetta Dell'Unto 2, Cristiano Alessandri 2, Manuela Di Franco 2, Carlo Perricone 3, Roberta Priori 2, Valeria Riccieri 2, Rossana Scrivo 2, Antonio Sili Scavalli 2, Simona Truglia 2, Guido Valesini 2, Fabrizio Conti 2 |
| 79 | |
Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons |
Front Med (Lausanne). 2020 Nov 23;7:601618. doi: 10.3389/fmed.2020.601618.eCollection 2020. Irene Llorente 1, Noelia García-Castañeda 1, Cristina Valero 1, Isidoro González-Álvaro 1, Santos Castañeda 1 2 |
| 80 | |
Rheumatoid arthritis medication adherence in a health system specialty pharmacy |
Am J Manag Care. 2020 Dec 1;26(12):e380-e387. doi: 10.37765/ajmc.2020.88544. Nate Berger 1, Megan Peter, Josh DeClercq, Leena Choi, Autumn D Zuckerman |
| 81 | |
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY |
Rheumatology (Oxford). 2020 Dec 11;keaa770. doi: 10.1093/rheumatology/keaa770.Online ahead of print. Vibeke Strand 1, Namita Tundia 2, Alvin Wells 3, Maya H Buch 4 5, Sebastiao C Radominski 6, Heidi S Camp 7, Alan Friedman 7, Jessica L Suboticki 8, Kendall Dunlap 8, Debbie Goldschmidt 9, Martin Bergman 10 |
| 82 | |
Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study |
J Clin Rheumatol. 2020 Dec 14;Publish Ahead of Print doi:10.1097/RHU.0000000000001616.Online ahead of print. Ingrid Strusberg 1, Eduardo Mysler, Gustavo Citera, Daniel Siri, Maria de Los Ángeles Correa, Maria Alicia Lazaro, Rodolfo Pardo Hidalgo, Alberto Spindler, Patricio Tate, Horacio Venarotti, Jorge Velasco Zamora, Ezequiel Klimovsky, Andrea Federico, Eduardo Scheines, Eliseo Gonzalez, Lucas Cordeiro, Nestor Lago |
| 83 | |
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis |
Rheumatology (Oxford). 2020 Dec 9;keaa557. doi: 10.1093/rheumatology/keaa557.Online ahead of print. Konstantinos Thomas, Argyro Lazarini 1, Evripidis Kaltsonoudis 2, Paraskevi V Voulgari 2, Alexandros A Drosos 2, Argyro Repa 3, Ainour Molla Ismail Sali 3, Prodromos Sidiropoulos 3, Panagiota Tsatsani 4, Sousana Gazi 4, Argyriou Evangelia 5, Kyriaki A Boki 5, Pelagia Katsimbri 1, Dimitrios Boumpas 1, Kalliopi Fragkiadaki 1, Maria G Tektonidou 1, Petros P Sfikakis 1, Konstantina Karagianni 6, Lazaros I Sakkas 6, Eleftheria P Grika 1, Panagiotis G Vlachoyiannopoulos 1, Gerasimos Evangelatos 7, Alexios Iliopoulos 7, Theodoros Dimitroulas 8, Alexandros Garyfallos 8, Konstantinos Melissaropoulos 9, Panagiotis Georgiou 9, Maria Areti 10, Constantinos Georganas 11, Periklis Vounotrypidis 12, Georgios Georgiopoulos 1, George D Kitas 1 13, Dimitrios Vassilopoulos 1 |
| 84 | |
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis |
Nat Rev Rheumatol. 2020 Dec 8. doi: 10.1038/s41584-020-00541-7.Online ahead of print. Maya H Buch 1 2 3, Stephen Eyre 4 5, Dennis McGonagle 6 7 |
| 85 | |
Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19 |
Rheumatol Int.2020 Nov 30;1-10. doi: 10.1007/s00296-020-04751-w. Online ahead of print. Sophia M Brady 1 2 3, Sally A M Fenton 1 2 3, George S Metsios 2 4, Ailsa Bosworth 5, Joan L Duda 1 3, George D Kitas 1 2, Jet J C S Veldhuijzen van Zanten 6 7 8 |
| 86 | |
Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients |
Arthritis Res Ther. 2020 Dec 4;22(1):282. doi: 10.1186/s13075-020-02355-0. Jeffrey R Curtis 1, Fenglong Xie 2, Cynthia S Crowson 3, Eric H Sasso 4 5, Elena Hitraya 4 5, Cheryl L Chin 4 5, Richard D Bamford 4 5, Rotem Ben-Shachar 5, Alexander Gutin 5, Darl D Flake 2nd 5, Brent Mabey 5, Jerry S Lanchbury 5 |
| 87 | |
A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis |
Rheumatol Ther. 2020 Nov 26. doi: 10.1007/s40744-020-00257-w. Online ahead of print. Christopher J Edwards 1, Ruta Sawant 2, Vishvas Garg 2, Ella X Du 3, Alan Friedman 2, Keith A Betts 4 |
| 88 | |
Update on the diagnosis and management of early rheumatoid arthritis |
Clin Med (Lond). 2020 Nov;20(6):561-564. doi: 10.7861/clinmed.2020-0727. |
| 89 | |
Rheumatoid arthritis and bone health |
Clin Med (Lond). 2020 Nov;20(6):565-567. doi: 10.7861/clinmed.20.6.rabh. |
| 90 | |
Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study |
Rheumatology (Oxford). 2020 Nov 17;keaa576. doi: 10.1093/rheumatology/keaa576.Online ahead of print. Josef S Smolen 1, Li Xie 2, Bochao Jia 2, Peter C Taylor 3, Gerd Burmester 4, Yoshiya Tanaka 5, Ayesha Elias 2, Anabela Cardoso 2, Rob Ortmann 2, Chad Walls 2, Maxime Dougados 6 |
| 91 | |
Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission on Combination Therapy: A Randomized, Double-Blind Trial |
Arthritis Rheumatol. 2020 Nov 18. doi: 10.1002/art.41589. Online ahead of print. Jeffrey R Curtis 1, Paul Emery 2, Elaine Karis 3, Boulos Haraoui 4, Vivian Bykerk 5, Priscilla K Yen 3, Greg Kricorian 3, James B Chung 3 |
| 92 | |
Joint Destruction Is Associated With All Types of Cardiovascular Events in French Rheumatoid Patients: A Real-Life Study With Very Long Follow-Up |
Front Med (Lausanne). 2020 Oct 30;7:556086. doi: 10.3389/fmed.2020.556086.eCollection 2020. Marie Robert 1, Arnaud Hot 2, François Mifsud 1, Ndiémé Ndongo-Thiam 1, Pierre Miossec 1 |
| 93 | |
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis |
Ann Rheum Dis. 2020 Nov 4;annrheumdis-2020-218412.doi: 10.1136/annrheumdis-2020-218412. Online ahead of print. Roy M Fleischmann 1, Ricardo Blanco 2, Stephen Hall 3, Glen T D Thomson 4, Filip E Van den Bosch 5 6, Cristiano Zerbini 7, Louis Bessette 8 9, Jeffrey Enejosa 10, Yihan Li 10, Yanna Song 10, Ryan DeMasi 10, In-Ho Song 10 |
| 94 | |
The Role of the Microbiome in Driving RA-Related Autoimmunity |
Front Cell Dev Biol. 2020 Sep 29;8:538130. doi: 10.3389/fcell.2020.538130.eCollection 2020. Cristopher M Rooney 1, Kulveer Mankia 1 2, Paul Emery 1 2 |
| 95 | |
The patient perspective of nurse-led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis |
J Clin Nurs. 2020 Oct 30. doi: 10.1111/jocn.15531. Online ahead of print. Anne-Marie Tetsche Sweeney 1 2, Candy McCabe 1 3 4, Caroline A Flurey 5, Joanna C Robson 1 2, Alice Berry 1 2, Pamela Richards 1 2, Mwidimi Ndosi 1 2 |
| 96 | |
Factors associated with disability in patients with rheumatoid arthritis with persistent moderate disease activity: a retrospective cohort study |
BMC Rheumatol. 2020 Oct 21;4:63. doi: 10.1186/s41927-020-00161-4. eCollection 2020. Ian C Scott 1 2, Julie Mount 3, Jane Barry 3, Bruce Kirkham 4 |
| 97 | |
Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort |
Rheumatol Ther. 2020 Oct 28. doi: 10.1007/s40744-020-00247-y. Online ahead of print. John M Davis 3rd 1, Elena Myasoedova 2, Tina M Gunderson 3, Cynthia S Crowson 2 3 |
| 98 | |
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme |
Ann Rheum Dis. 2020 Oct 28;annrheumdis-2020-218510.doi: 10.1136/annrheumdis-2020-218510. Online ahead of print. Stanley B Cohen 1, Ronald F van Vollenhoven 2, Kevin L Winthrop 3, Cristiano A F Zerbini 4, Yoshiya Tanaka 5, Louis Bessette 6, Ying Zhang 7, Nasser Khan 7, Barbara Hendrickson 7, Jeffrey V Enejosa 7, Gerd R Burmester 8 |
| 99 | |
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme |
RMD Open. 2020 Oct;6(3):e001395. doi: 10.1136/rmdopen-2020-001395. Stanley B Cohen 1, Yoshiya Tanaka 2, Xavier Mariette 3, Jeffrey R Curtis 4, Eun Bong Lee 5, Peter Nash 6, Kevin L Winthrop 7, Christina Charles-Schoeman 8, Lisy Wang 9, Connie Chen 10, Kenneth Kwok 10, Pinaki Biswas 10, Andrea Shapiro 11, Ann Madsen 10, Jürgen Wollenhaupt 12 |
| 100 | |
Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions |
Peter Hanlon 1, Elaine Butterly 1, Jim Lewsey 1, Stefan Siebert 2, Frances S Mair 1, David A McAllister 3 |
| 101 | |
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib |
Arthritis Res Ther. 2020 Oct 15;22(1):243. doi: 10.1186/s13075-020-02324-7. Vibeke Strand 1, Jeffrey Kaine 2, Rieke Alten 3, Gene Wallenstein 4, Annette Diehl 5, Harry Shi 5, Rebecca Germino 6, Christopher W Murray 7 |
| 102 | |
Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available |
Arthritis Res Ther. 2020 Oct 15;22(1):242. doi: 10.1186/s13075-020-02310-z. Jeffrey R Curtis 1 2 3, Fenglong Xie 4, Hong Zhou 4, David Salchert 4, Huifeng Yun 4 5 |
| 103 | |
Long-term Glucocorticoid Use in Rheumatoid Arthritis |
J Rheumatol. 2020 Oct 15;jrheum.201137. doi: 10.3899/jrheum.201137. Online ahead of print. Maarten Boers 1, Theodore Pincus 1 |
| 104 | |
10-year follow-up of patients with rheumatoid arthritis and secondary Sjögren |
Clin Exp Rheumatol. 2020 Sep 23. Online ahead of print. Rada V Moerman 1, Suzanne Arends 1, Esther Mossel 1, Frans G M Kroese 1, Arjan Vissink 2, Hendrika Bootsma 3 |
| 105 | |
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis |
Adv Ther. 2020 Oct 9. doi: 10.1007/s12325-020-01501-z. Online ahead of print. Stanley B Cohen 1, Jeffrey D Greenberg 2, James Harnett 3, Ann Madsen 4, Timothy W Smith 4, David Gruben 5, Richard Zhang 4, Tatjana Lukic 4, John Woolcott 6, Kimberly J Dandreo 2, Heather J Litman 2, Taylor Blachley 2, Anne Lenihan 7, Connie Chen 4, Jose L Rivas 8, Maxime Dougados 9 10 |
| 106 | |
Implementation and Evaluation of Audit and Feedback for Monitoring Treat-to-Target (T2T) Strategies in Rheumatoid Arthritis Using Performance Measures |
Rheumatol Ther. 2020 Oct 9. doi: 10.1007/s40744-020-00237-0. Online ahead of print. Claire E H Barber 1 2 3, Dianne Mosher 4, Shawn Dowling 4, Victoria Bohm 4, Nathan M Solbak 4, Paul MacMullan 4, Bo Pan 5, Cheryl Barnabe 4 6 7, Glen S Hazlewood 4 6 7, Karen L Then 8, Deborah A Marshall 4 6 7, James A Rankin 8, Linda C Li 7 9, Karen Tsui 10, Kelly English 10, Joanne Homik 11, Nicole Spencer 4, Marc Hall 8, Diane Lacaille 7 12 |
| 107 | |
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis |
Clin Rheumatol. 2020 Oct 11. doi: 10.1007/s10067-020-05402-y. Online ahead of print. Hilde Berner Hammer 1 2, Brigitte Michelsen 3 4, Joe Sexton 3, Till Uhlig 3 5, Sella A Provan 3 |
| 108 | |
EULAR recommendations for a core data set for pregnancy registries in rheumatology |
Ann Rheum Dis. 2020 Oct 14;annrheumdis-2020-218356.doi: 10.1136/annrheumdis-2020-218356. Online ahead of print. Yvette Meissner 1, Rebecca Fischer-Betz 2, Laura Andreoli 3 4, Nathalie Costedoat-Chalumeau 5 6, Diederik De Cock 7, Radboud J E M Dolhain 8, Frauke Forger 9, Doreen Goll 10, Anna Molto 11 12, Catherine Nelson-Piercy 13 14, Rebecca Özdemir 15, Luigi Raio 16, Sebastian Cruz Rodríguez-García 17, Savino Sciascia 18, Marianne Wallenius 19 20, Astrid Zbinden 9, Angela Zink 21, Anja Strangfeld 21 |
| 109 | |
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women |
Arthritis Care Res (Hoboken). 2020 Oct 1. doi: 10.1002/acr.24471. Online ahead of print. Jeffrey R Curtis 1, Michael Weinblatt 2, Kenneth Saag 1, Vivian P Bykerk 3, Daniel E Furst 4 5 6, Stefano Fiore 7, Gregory St John 8, Toshio Kimura 8, Shen Zheng 7, Clifton O Bingham 3rd 9, Grace Wright 10, Martin Bergman 11, Kamala Nola 12, Christina Charles-Schoeman 4, Nancy Shadick 2 |
| 110 | |
Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials |
Nutrients. 2020 Sep 29;12(10):E2991. doi: 10.3390/nu12102991. Josefine Nelson 1, Helen Sjöblom 2, Inger Gjertsson 3, Stine M Ulven 4, Helen M Lindqvist 5, Linnea Bärebring 5 |
| 111 | |
Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study |
J Rheumatol. 2020 Oct 1;jrheum.191252. doi: 10.3899/jrheum.191252. Online ahead of print. Anat Fisher 1, Marie Hudson 1, Robert W Platt 1, Colin R Dormuth, Canadian Network for Observational Drug Effect Studies (CNODES) Investigators |
| 112 | |
24-hour Activity and Sleep Profiles for Adults Living with Arthritis: Habits Matter |
Arthritis Care Res (Hoboken). 2020 Oct 6. doi: 10.1002/acr.24424. Online ahead of print. Lynne M Feehan 1, Na Lu 2, Hui Xie 2, Linda C Li 1 |
| 113 | |
Weight Fluctuation and the Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2020 Oct 1. doi: 10.1002/acr.24469. Online ahead of print. Joshua F Baker 1 2 3, George Reed 4 5, Joel Kremer 6 7 |
| 114 | |
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study |
Lancet Rheumatol. 2020 Sep 21. doi: 10.1016/S2665-9913(20)30305-2. Online ahead of print. Chris A Gentry 1, Mary Beth Humphrey 2 3, Sharanjeet K Thind 4 5, Sage C Hendrickson 1, George Kurdgelashvili 4 5, Riley J Williams 2nd 1 |
| 115 | |
Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry |
ACR Open Rheumatol. 2020 Sep 29.doi: 10.1002/acr2.11168. Online ahead of print. Dimitrios A Pappas 1, Ying Shan 2, Tamara Lesperance 3, Greg Kricorian 4, Elaine Karis 4, Sabrina Rebello 2, Winnie Hua 2, Neil A Accortt 4, Scott Stryker 4 |
| 116 | |
Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies |
Sci Rep. 2020 Sep 29;10(1):16006. doi: 10.1038/s41598-020-71676-6. Tomoya Ohno 1 2, Dagfinn Aune 3 4 5, Alicia K Heath 1 |
| 117 | |
Incidence and Complication Rates for Total Hip Arthroplasty in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Across Four Decades |
Rheumatol Ther. 2020 Sep 30. doi: 10.1007/s40744-020-00238-z.Online ahead of print. Owen Taylor-Williams 1, Johannes Nossent 2 3, Charles A Inderjeeth 4 5 |
| 118 | |
JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data |
J Inflamm Res. 2020 Sep 14;13:519-531. doi: 10.2147/JIR.S219586.eCollection 2020. Robert Harrington # 1, Shamma Ahmad Al Nokhatha # 1, Richard Conway 1 |
| 119 | |
A cross-sectional study of sleep and depression in a rheumatoid arthritis population |
Clin Rheumatol. 2020 Sep 24. doi: 10.1007/s10067-020-05414-8. Online ahead of print. Mark Hughes 1, Alan Chalk 2, Poonam Sharma 3, Sandeep Dahiya 3, James Galloway 4 |
| 120 | |
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity |
Rheum Dis Clin North Am. 2020 Nov;46(4):685-692. doi: 10.1016/j.rdc.2020.07.005.Epub 2020 Sep 9. Cheryl Barnabe 1 |
| 121 | |
The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study |
Rheumatol Adv Pract. 2020 Sep 16;4(2):rkaa041. doi: 10.1093/rap/rkaa041. eCollection 2020. James Galloway 1, Jean-Philippe Capron 2, Francesco De Leonardis 3, Walid Fakhouri 4, Alison Rose 5, Ilias Kouris 6, Tom Burke 5 |
| 122 | |
Depression and subsequent risk for incident rheumatoid arthritis among women |
Arthritis Care Res (Hoboken). 2020 Sep 16.doi: 10.1002/acr.24441. Online ahead of print. Jeffrey A Sparks 1 2, Susan Malspeis 1, Jill Hahn 1 2, Jiaqi Wang 1, Andrea L Roberts 3, Laura D Kubzansky 2 3, Karen H Costenbader 1 2 |
| 123 | |
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study |
Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-1594. Online ahead of print. Michael D George 1, Joshua F Baker 2, Kevin Winthrop 3, Jesse Y Hsu 1, Qufei Wu 1, Lang Chen 4, Fenglong Xie 4, Huifeng Yun 4, Jeffrey R Curtis 4 |
| 124 | |
Positive Psychological Factors and Impairment in Rheumatic and Musculoskeletal Disease: Do Psychopathology and Sleep Quality Explain the Linkage? |
Arthritis Care Res (Hoboken). 2020 Sep 16. doi: 10.1002/acr.24440. Online ahead of print. Jameson K Hirsch 1, Heather R Altier 1, Martin Offenbächer 2, Loren Toussaint 3, Niko Kohls 4, Fuschia M Sirois 5 |
| 125 | |
Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: influence of demographic factors |
Joint Bone Spine. 2020 Sep 10;S1297-319X(20)30156-1. doi: 10.1016/j.jbspin.2020.09.003.Online ahead of print. Catia Duarte 1, Eduardo Santos 2, Tore K Kvien 3, Maxime Dougados 4, Maarten de Wit 5, Laure Gossec 6, J A P da Silva 7 |
| 126 | |
Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis |
ACR Open Rheumatol. 2020 Sep 13. doi: 10.1002/acr2.11175. Online ahead of print. Luke W Desilet 1, Bryant R England 1, Kaleb Michaud 2, Jennifer L Barton 3, Ted R Mikuls 1, Joshua F Baker 4 |
| 127 | |
The clinical effectiveness of intensive management in moderate established rheumatoid arthritis: The titrate trial |
Semin Arthritis Rheum. 2020 Jul 30;50(5):1182-1190. doi: 10.1016/j.semarthrit.2020.07.014.Online ahead of print. David Scott 1, Fowzia Ibrahim 2, Harry Hill 3, Brian Tom 4, Louise Prothero 1, Rhiannon R Baggott 1, Ailsa Bosworth 5, James B Galloway 1, Sofia Georgopoulou 1, Naomi Martin 1, Isabel Neatrour 1, Elena Nikiphorou 1, Jackie Sturt 6, Allan Wailoo 3, Frances Mk Williams 7, Ruth Williams 1, Heidi Lempp 1 |
| 128 | |
Reliability and Change in Erosion Measurements by High-Resolution peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis Patients |
J Rheumatol. 2020 Sep 15;jrheum.191391. doi: 10.3899/jrheum.191391. Online ahead of print. Stephanie Finzel 1, Sarah L Manske 1, Cheryl Barnabe 1, Andrew J Burghardt 1, Hubert Marotte 1, Andrea Scharmga 1, Ellen-Margrethe Hauge 1, Roland Chapurlat 1, Klaus Engelke 1, Xiaojuan Li 1, Bente van Teeffelen 1, Philip G Conaghan 1, Kathryn S Stok 1 |
| 129 | |
Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials |
JAMA Netw Open. 2020 Sep 1;3(9):e2013196. doi: 10.1001/jamanetworkopen.2020.13196. Jan Vollert 1 2, Nancy R Cook 1, Ted J Kaptchuk 3, Shiv T Sehra 4, Deirdre K Tobias 1, Kathryn T Hall 1 |
| 130 | |
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study |
Lancet Rheumatol. 2020 Aug 21. doi: 10.1016/S2665-9913(20)30276-9. Online ahead of print. Jennifer C E Lane 1, James Weaver 2, Kristin Kostka 3, Talita Duarte-Salles 4, Maria Tereza F Abrahao 5, Heba Alghoul 6, Osaid Alser 7, Thamir M Alshammari 8, Patricia Biedermann 9, Juan M Banda 10, Edward Burn 1 4, Paula Casajust 11, Mitchell M Conover 2, Aedin C Culhane 12, Alexander Davydov 13, Scott L DuVall 14 15, Dmitry Dymshyts 13, Sergio Fernandez-Bertolin 4, Kristina Fišter 16, Jill Hardin 2, Laura Hester 2, George Hripcsak 17 18, Benjamin Skov Kaas-Hansen 19 20, Seamus Kent 21, Sajan Khosla 22, Spyros Kolovos 1, Christophe G Lambert 23, Johan van der Lei 24, Kristine E Lynch 14 15, Rupa Makadia 2, Andrea V Margulis 25, Michael E Matheny 26 27, Paras Mehta 28, Daniel R Morales 29, Henry Morgan-Stewart 3, Mees Mosseveld 24, Danielle Newby 30, Fredrik Nyberg 31, Anna Ostropolets 17, Rae Woong Park 32, Albert Prats-Uribe 1, Gowtham A Rao 2, Christian Reich 3, Jenna Reps 2, Peter Rijnbeek 24, Selva Muthu Kumaran Sathappan 33, Martijn Schuemie 2, Sarah Seager 3, Anthony G Sena 2 24, Azza Shoaibi 2, Matthew Spotnitz 17, Marc A Suchard 34, Carmen O Torre 3, David Vizcaya 35, Haini Wen 36, Marcel de Wilde 24, Junqing Xie 1, Seng Chan You 32, Lin Zhang 37 38, Oleg Zhuk 13, </ |
| 131 | |
Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review |
ACR Open Rheumatol. 2020 Sep 1. doi: 10.1002/acr2.11170. Online ahead of print. Christina M Daniel 1, Lesley Davila 1, Una E Makris 2, Helen Mayo 3, Liron Caplan 4, Lisa Davis 5, E Blair Solow 1 |
| 132 | |
Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis |
Medicine (Baltimore). 2020 Aug 28;99(35):e21827. doi: 10.1097/MD.0000000000021827. Jennifer Reams 1, Andrea Berger, Alfred Denio |
| 133 | |
Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis |
Ann Rheum Dis. 2020 Aug 28;annrheumdis-2020-217653.doi: 10.1136/annrheumdis-2020-217653. Online ahead of print. Sven Plein 1, Bara Erhayiem 1, Graham Fent 1, Sarah Horton 2, Raluca Bianca Dumitru 3, Jacqueline Andrews 3, John P Greenwood 1, Paul Emery 3 4, |
| 134 | |
Certain perspectives about the use of corticosteroids for managing hospitalized patients with rheumatic diseases |
Clin Rheumatol. 2020 Aug 24. doi: 10.1007/s10067-020-05349-0.Online ahead of print. Sky Wang 1, Richard S Panush 2 |
| 135 | |
Complementary and Alternative Medicine Use in Rheumatoid Arthritis |
Curr Rheumatol Rep. 2020 Aug 26;22(10):61. doi: 10.1007/s11926-020-00938-z. Sara Baig 1, Dana D DiRenzo 2 |
| 136 | |
Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation |
World J Gastrointest Pathophysiol. 2020 Aug 12;11(5):104-113.doi: 10.4291/wjgp.v11.i5.104. Simcha Weissman 1, Preetika Sinh 2, Tej I Mehta 3, Rishi K Thaker 4, Abraham Derman 5, Caleb Heiberger 3, Nabeel Qureshi 1, Viralkumar Amrutiya 1, Adam Atoot 1, Maneesh Dave 6, James H Tabibian 7 |
| 137 | |
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype |
Rheumatology (Oxford). 2020 Aug 18;keaa330. doi: 10.1093/rheumatology/keaa330.Online ahead of print. Karin Hellgren 1, Daniela Di Giuseppe 1, Karin E Smedby 1, Christer Sundström 2, Johan Askling 1, Eva Baecklund 3 |
| 138 | |
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries |
Rheumatology (Oxford). 2020 Aug 18;keaa393. doi: 10.1093/rheumatology/keaa393.Online ahead of print. Delphine S Courvoisier 1, Katarina Chatzidionysiou 2, Denis Mongin 1, Kim Lauper 1 3, Xavier Mariette 4, Jacques Morel 5, Jacques-Eric Gottenberg 6, Sytske Anne Bergstra 7, Manuel Pombo Suarez 8, Catalin Codreanu 9, Tore K Kvien 10, Maria Jose Santos 11, Karel Pavelka 12, Merete L Hetland 13 14, Johan Askling 15, Carl Turesson 16, Satoshi Kubo 17, Yoshiya Tanaka 17, Florenzo Iannone 18, Denis Choquette 19, Dan C Nordström 20, Ziga Rotar 21, Galina Lukina 22, Cem Gabay 1, Ronald Van Vollenhoven 22, Axel Finckh 1 Free article |
| 139 | |
Simple Erosion Narrowing Score of the hands as a predictor of cervical spine subluxation in rheumatoid arthritis |
SA J Radiol. 2020 Jul 27;24(1):1876. doi: 10.4102/sajr.v24i1.1876. eCollection 2020. Eric Gous 1, Mahmood M T M Ally 2, Pieter W A Meyer 3, Farhana E Suleman 1 |
| 140 | |
Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis |
Rheumatol Ther. 2020 Aug 14. doi: 10.1007/s40744-020-00226-3. Online ahead of print. Martin J Bergman 1, Alan J Kivitz 2, Dimitrios A Pappas 3 4, Joel M Kremer 5, Lixia Zhang 6, Anna Jeter 6, Johanna B Withers 7 |
| 141 | |
Enhancing Patient Understanding of Medication Risks and Benefits |
Arthritis Care Res (Hoboken). 2020 Aug 16. doi: 10.1002/acr.24421. Online ahead of print. Susan J Blalock 1, Elizabeth B Solow 2, Valerie F Reyna 3, Molly Keebler 4, Delesha Carpenter 1, Caprice Hunt 1, Genevieve Hickey 1, Kimberlee O'Neill 1, Jeffrey R Curtis 5, Sandra Bond Chapman 4 |
| 142 | |
Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis |
Sci Rep. 2020 Aug 18;10(1):13975. doi: 10.1038/s41598-020-70942-x. J P M Blair 1 2, A-C Bay-Jensen 3, M H Tang 4, P Frederiksen 3, C Bager 4, M Karsdal 3, S Brunak 5 |
| 143 | |
Brief Report: Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits |
Arthritis Care Res (Hoboken). 2020 Aug 19. doi: 10.1002/acr.24429. Online ahead of print. Bryant R England 1, Claire E H Barber 2 3, Martin Bergman 4, Veena K Ranganath 5, Lisa G Suter 6, Kaleb Michaud 1 7 |
| 144 | |
Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI) |
Rheumatology (Oxford). 2020 Aug 13;keaa343. doi: 10.1093/rheumatology/keaa343.Online ahead of print. Janet E Pope 1, Emmanouil Rampakakis 2, Mohammad Movahedi 3 4, Angela Cesta 3, John S Sampalis 2 5, Claire Bombardier 3 6 7 |
| 145 | |
A Serum Protein Signature is associated with Rheumatoid Arthritis development |
Arthritis Rheumatol. 2020 Aug 7. doi: 10.1002/art.41483. Online ahead of print. Liam J O'Neil 1, Victor Spicer 1, Irene Smolik 1, Xiaobo Meng 1, Rishi R Goel 2, Vidyanand Anaparti 1, John Wilkins 1, Hani S El-Gabalawy 1 |
| 146 | |
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis |
Ann Rheum Dis. 2020 Aug 11;annrheumdis-2019-216852.doi: 10.1136/annrheumdis-2019-216852. Online ahead of print. Kevin L Winthrop 1, Masayoshi Harigai 2, Mark C Genovese 3, Stephen Lindsey 4, Tsutomu Takeuchi 5, Roy Fleischmann 6, John D Bradley 7, Nicole L Byers 7, David L Hyslop 7, Maher Issa 7, Atsushi Nishikawa 8, Terence P Rooney 7, Sarah Witt 7, Christina L Dickson 7, Josef S Smolen 9, Maxime Dougados 10 |
| 147 | |
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data |
Ann Rheum Dis. 2020 Aug 5;annrheumdis-2019-216761.doi: 10.1136/annrheumdis-2019-216761. Online ahead of print. Philip Mease 1, Christina Charles-Schoeman 2, Stanley Cohen 3, Lara Fallon 4, John Woolcott 5, Huifeng Yun 6, Joel Kremer 7, Jeffrey Greenberg 8, Wendi Malley 8, Alina Onofrei 8, Keith S Kanik 9, Daniela Graham 9, Cunshan Wang 10, Carol Connell 11, Hernan Valdez 12, Manfred Hauben 13 14, Eric Hung 13, Ann Madsen 15, Thomas V Jones 16, Jeffrey R Curtis 17 |
| 148 | |
Methotrexate Pulmonary Toxicity: Deep Inspirati |
Arthritis Rheumatol. 2020 Jul 27. doi: 10.1002/art.41451. Online ahead of print. Joel M Kremer 1 |
| 149 | |
Vitamin D and early rheumatoid arthritis |
BMC Rheumatol. 2020 Jul 27;4:38. doi: 10.1186/s41927-020-00134-7. eCollection 2020. Stephanie R Harrison 1 2, Gurpreet Jutley 3, Danyang Li 1, Ilfita Sahbudin 3, Andrew Filer 3, Martin Hewison 1 4, Karim Raza 2 3 |
| 150 | |
Disease modifying anti-rheumatic drugs, biologics and corticosteroid use in older patients with rheumatoid arthritis over 20 years |
J Rheumatol. 2020 Aug 1;jrheum.200310. doi: 10.3899/jrheum.200310. Online ahead of print. John G Hanly 1, Lynn Lethbridge 1 |
| 151 | |
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis |
Curr Rheumatol Rep. 2020 Aug 1;22(9):56. doi: 10.1007/s11926-020-00933-4. Dilli Poudel 1, Michael D George 1 2, Joshua F Baker 3 4 5 6 |
| 152 | |
Rhupus: a systematic literature review |
Autoimmun Rev. 2020 Jul 12;102612. doi: 10.1016/j.autrev.2020.102612.Online ahead of print. Luca Antonini 1, Brigitte Le Mauff 2, Christian Marcelli 3, Achille Aouba 4, Hubert de Boysson 5 |
| 153 | |
Abdominal Obesity in Comparison with General Obesity and Risk of Developing Rheumatoid Arthritis in Women |
J Rheumatol. 2020 Jul 15;jrheum.200056. doi: 10.3899/jrheum.200056. Online ahead of print. Nathalie E Marchand 1, Jeffrey A Sparks 1, Sara K Tedeschi 1, Susan Malspeis 1, Karen H Costenbader 1, Elizabeth W Karlson 1, Bing Lu 1 |
| 154 | |
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases |
Clin Exp Immunol. 2020 Jul 16. doi: 10.1111/cei.13495. Online ahead of print. David Baker 1, Charles Ak Roberts 1, Gareth Pryce 1, Angray S Kang 1 2, Monica Marta 1 3, Saul Reyes 1 3, Klaus Schmierer 1 3, Gavin Giovannoni 1 3, Sandra Amor 1 4 |
| 155 | |
Promoting engagement in physical activity in early rheumatoid arthritis: A proof-of-concept intervention study |
Musculoskeletal Care. 2020 Jul 14. doi: 10.1002/msc.1493. Online ahead of print. Fiona Cramp 1, Rachel Thomas 1, Anne M Haase 1 2 3, Melissa Domaille 1 4, Sarah Manns 1, Caroline Swales 1 5, Judy Hurfurt 1 5, Nicola E Walsh 1 |
| 156 | |
Methotrexate and rheumatoid arthritis associated interstitial lung disease |
Eur Respir J. 2020 Jul 9;2000337. doi: 10.1183/13993003.00337-2020. Online ahead of print. Pierre-Antoine Juge 1 2, Joyce S Lee 3 2, Jessica Lau 4 2, Leticia Kawano-Dourado 5, Jorge Rojas Serrano 6, Marco Sebastiani 7, Gouri Koduri 8, Eric Matteson 9 10, Karina Bonfiglioli 11, Marcio Sawamura 12, Ronaldo Kairalla 5, Lorenzo Cavagna 13, Emanuele Bozzalla Cassione 13, Andreina Manfredi 7, Mayra Mejia 6, Pedro Rodríguez-Henriquez 14, Montserrat I González-Pérez 6, Ramcés Falfán-Valencia 15, Ivette Buendia-Roldán 16, Gloria Pérez-Rubio 15, Esther Ebstein 1, Steven Gazal 17 18, Raphaël Borie 19, Sébastien Ottaviani 1, Caroline Kannengiesser 20, Benoît Wallaert 21, Yurdagul Uzunhan 22, Hilario Nunes 22, Dominique Valeyre 22, Nathalie Saidenberg-Kermanac'h 23, Marie-Christophe Boissier 23, Lidwine Wemeau-Stervinou 21, René-Marc Flipo 24, Sylvain Marchand-Adam 25, Pascal Richette 26 27, Yannick Allanore 28 29, Claire Dromer 30, Marie-Elise Truchetet 31, Christophe Richez 31, Thierry Schaeverbeke 31, Huguette Lioté 32, Gabriel Thabut 33, Kevin D Deane 3, Joshua Solomon 34, Tracy Doyle 35, Jay H Ryu 4, Ivan Rosas 35, V Michael Holers 3, Catherine Boileau 20, Marie-Pierre Debray 36, Raphaël Porcher 37 38, David A Schwartz 3, Robert Vassallo 4, Bruno Crestani 20 2, Philippe Dieudé 39 2 |
| 157 | |
Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients |
Int J Clin Res Trials. 2020;5(1):145. doi: 10.15344/2456-8007/2020/145. Epub 2020 Apr 25. Isabel M McFarlane 1, Manjeet S Bhamra 2, Abhimnayu Amarnani 1, Su Yien Zhaz 3, Srinivas Kolla 4, Milena Rodriguez Alvarez 1, George Mo 1, Maya Srinivasan 1, Gil Hevroni 1, Talia Meisel 1, Abida Hasan 1, Marie S Baguidy 1, Michael Hadaddin 1, Adielle Melamed 1, Kristaq Koci 1, Nicholas Taklalsingh 1, Joshy Pathiparampil 1, Latoya Freeman 1, Ian Kaplan 1, Naureen Kabani 1, David J Ozeri 5, Elsie Watler 1, Mosab Frefer 1, Vytas Vaitkus 1, Keron Matthew 1, Fray Arroyo-Mercado 1, Helen Lyo 1, Aleksander Feoktistov 1, Randolph Sanchez 6, Faisal Soliman 7, Felix Reyes Valdez 8, Veena Dronamraju 1, Michael Trevisonno 1, Christon Grant 1, Guerrier Clerger 1, Kunfeng Sun 1, Khabbab Amin 1, Makeda Dawkins 1, Jason Green 1, Samir Fahmy 3, Apoorva Jayarangaiah 9, Stephen Anthony Waite 4, Aaliya Burza 10 |
| 158 | |
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis? |
Clin Exp Rheumatol. 2020 Jun 30.Online ahead of print. Frederique Ponchel 1, Myrthe A M van Delft 2, Xuanxiao Xie 3, Agata N Burska 3, Laurence Duquenne 3, Leendert A Trouw 4, Paul Emery 5 |
| 159 | |
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis |
Clin Exp Rheumatol. 2020 Jul 10. Online ahead of print. Christof Specker 1, Annette Alberding 2, Martin Aringer 3, Gerd-Rüdiger Burmester 4, Jan-Paul Flacke 5, Michael W Hofmann 6, Peter Kästner 7, Herbert Kellner 8, Frank Moosig 9, Maren Sieburg 10, Hans-Peter Tony 11, Gerhard Fliedner 12 |
| 160 | |
Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions |
Int J Mol Sci. 2020 Jun 30;21(13):4645.doi: 10.3390/ijms21134645. Robert Root-Bernstein 1 |
| 161 | |
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage study |
LoS One. 2020 Jun 18;15(6):e0234813. doi: 10.1371/journal.pone.0234813. eCollection 2020. Emma Foster 1 2 3, Michael J Malloy 4 5, Vilija G Jokubaitis 1 2, C David H Wrede 6 7, Helmut Butzkueven 1 2, Joe Sasadeusz 8, Sharon Van Doornum 9 10, Finlay Macrae 11, Gary Unglik 12, Julia M L Brotherton 4 5, Anneke van der Walt 1 2 3 |
| 162 | |
Rheumatoid Arthritis: Pathogenesis, Prediction and Prevention - An Emerging Paradigm Shift |
Arthritis Rheumatol. 2020 Jun 30. doi: 10.1002/art.41417. Online ahead of print. Kevin D Deane 1, V Michael Holers 1 |
| 163 | |
Disease Modifying Anti-Rheumatic Drugs (DMARD) |
Onecia Benjamin 1, Pankaj Bansal 2, Amandeep Goyal 3, Sarah L. Lappin 4 In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Jul 4. |
| 164 | |
Using a Discrete-Choice Experiment in a Decision Aid to Nudge Patients Towards Value-Concordant Treatment Choices in Rheumatoid Arthritis: A Proof-of-Concept Study |
Patient Prefer Adherence. 2020 May 18;14:829-838. doi: 10.2147/PPA.S221897.eCollection 2020. Glen S Hazlewood 1 2 3, Deborah A Marshall 1 2 3, Claire E H Barber 1 2 3, Linda C Li 3, Cheryl Barnabe 1 2 3, Vivian Bykerk 4 5, Peter Tugwell 6, Pauline M Hull 7, Nick Bansback 3 8 |
| 165 | |
SB4 in the Era of Biosimilars: Clinical Data and Real-World Experience |
Mediterr J Rheumatol. 2019 May 31;30(Suppl 1):59-62. doi: 10.31138/mjr.30.1.59.eCollection 2019 Jun. Shing T Law 1, Peter C Taylor 1 |
| 166 | |
Selection and Perception of Methotrexate Treatment Information in People With Rheumatoid Arthritis |
Int J Rheum Dis. 2020 Jun;23(6):805-812. doi: 10.1111/1756-185X.13833. Epub 2020 Jun 14. Nieves Leonardo 1, Susan Lester 1 2, Michelle Graham 3, Claire Barrett 4 5, Samuel Whittle 1, Debra Rowett 6 7, Rachelle Buchbinder 8 9, Catherine L Hill 1 2 |
| 167 | |
Up to 5-year Retention of Abatacept in Belgian Patients With Moderate-To-Severe Rheumatoid Arthritis: A Sub-Analysis of the International, Observational ACTION Study |
Rheumatol Int. 2020 Jun 17. doi: 10.1007/s00296-020-04619-z. Online ahead of print. R Westhovens 1, S E Connolly 2, J Margaux 3, M Vanden Berghe 4, M Maertens 5, M Van den Berghe 6, Y Elbez 7, M Chartier 8, F Baeke 9, S Robert 9, M Malaise 10 |
| 168 | |
Lack of Association Between Clinical and Ultrasound Measures of Disease Activity in Rheumatoid Arthritis Remission |
Ther Adv Musculoskelet Dis. 2020 May 11;12:1759720X20915322.doi: 10.1177/1759720X20915322. eCollection 2020. Kenneth F Baker 1, Ben Thompson 1, Dennis W Lendrem 1, Adam Scadeng 2, Arthur G Pratt 1, John D Isaacs 3 |
| 169 | |
Prevalence of and Changes in Tooth Loss Among Adults Aged =50 Years With Selected Chronic Conditions - United States, 1999-2004 and 2011-2016 |
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):641-646 doi: 10.15585/mmwr.mm6921a1. Marcia L Parker, Gina Thornton-Evans, Liang Wei, Susan O Griffin |
| 170 | |
Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2020 May 31. doi: 10.1002/acr.24341. Online ahead of print. Joshua F Baker 1 2 3, Andrew Stokes 4, Sofia Pedro 5, Ted R Mikuls 6, Michael George 2, Bryant R England 6, Harlan Sayles 6, Fred Wolfe 5, Kaleb Michaud 5 6 |
| 171 | |
Adaptive Engagement and Support Model for People With Chronic Health Conditions: Using Combined Content Analysis to Assess Online Health Communities |
J Med Internet Res. 2020 Jun 3. doi: 10.2196/17338. Online ahead of print. Brian M Green 1, Katelyn Tente Van Horn 1, Ketki Gupte 1, Megan Evans 2, Sara Hayes 1, Amrita Bhowmick 1 2 |
| 172 | |
Safety of Repository Corticotropin Injection as an Adjunctive Therapy for the Treatment of Rheumatoid Arthritis |
Expert Opin Drug Saf. 2020 Jun 16;1-10. doi: 10.1080/14740338.2020.1779219.Online ahead of print. Roy Fleischmann 1, Daniel E Furst 2 |
| 173 | |
Adopting PROs in Virtual and Outpatient Management of RA |
Nat Rev Rheumatol. 2020 Jun 5;1-2. doi: 10.1038/s41584-020-0449-6. Online ahead of print. Peter C Talo1 |
| 174 | |
Cannabis-based Medicinal Products in Arthritis, a Painful Conundrum |
N Z Med J. 2020 May 22;133(1515):35-45. Marthe Van den Berg 1, Mary John 2, Melissa Black 3, Alex Semprini 4, Karen Oldfield 5, Michelle Glass 6, Irene Braithwaite 4 |
| 175 | |
A Mixed Methods Evaluation of an Individualised Yoga Therapy Intervention for Rheumatoid Arthritis: Pilot Study |
Complement Ther Med. 2020 May;50:102339.doi: 10.1016/j.ctim.2020.102339.Epub 2020 Feb 6. Tina Cartwright 1, Margaret Cahill 1, Vidhi Sadana 2 |
| 176 | |
Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study |
JMIR Form Res. 2020 May 27;4(3):e15158. doi: 10.2196/15158. Sonali Desai # 1, Emma Stevens 1, Srinivas Emani 2, Peter Meyers 3, Maura Iversen 4, Daniel H Solomon 5 |
| 177 | |
Reliability, Feasibility, and Patient Acceptance of an Electronic Version of a Multidimensional Health Assessment Questionnaire for Routine Rheumatology Care: Validation and Patient Preference Study |
JMIR Form Res. 2020 May 27;4(5):e15815. doi: 10.2196/15815. Theodore Pincus 1, Isabel Castrejon 1 2, Mariam Riad 1, Elena Obreja 1, Candice Lewis 1, Niels Steen Krogh 3 |
| 178 | |
Patient and Clinician Views on an App for Rheumatoid Arthritis Disease Monitoring: Function, Implementation and Implications |
Int J Rheum Dis. 2020 May 18. doi: 10.1111/1756-185X.13850. Online ahead of print. Rebecca Grainger 1 2, Hermaleigh Roberta Townsley 1, Catherine Anna Ferguson 1, Faye Ellen Riley 1, Tobias Langlotz 3, William John Taylor 1 2 |
| 179 | |
Comparison of Infection-Related Hospitalization Risk and Costs in Tumor Necrosis Factor Inhibitor-Experienced Patients With Rheumatoid Arthritis (RA) Treated With Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs (tDMARDs) |
Med Econ. 2020 Jun 13;1-7. doi: 10.1080/13696998.2020.1772271. Online ahead of print. Damemarie Paul 1, Dhaval Patil 1, Laura McDonald 1, Vardhaman Patel 1, Francis Lobo 1 |
| 180 | |
A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFa-Blockade in Rheumatoid Arthritis Patients |
Front Immunol. 2020 May 5;11:845. doi: 10.3389/fimmu.2020.00845. eCollection 2020. Alessandra Nerviani 1, Maria Di Cicco 1, Arti Mahto 1, Gloria Lliso-Ribera 1, Felice Rivellese 1, Georgina Thorborn 1, Rebecca Hands 1, Mattia Bellan 1, Daniele Mauro 1, Marie-Astrid Boutet 1, Giovanni Giorli 1, Myles Lewis 1, Stephen Kelly 1, Michele Bombardieri 1, Frances Humby 1, Costantino Pitzalis 1 |
| 181 | |
Siblings of Patients With Rheumatoid Arthritis Have an Increased Mortality Rate: A Swedish Cohort Study |
RMD Open. 2020 May;6(1):e001197. doi: 10.1136/rmdopen-2020-001197. Helga Westerlind 1, Bénédicte Delcoigne 2, Johan Askling 2 |
| 182 | |
Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network |
Clin Med 2020 May 19;9(5):E1528.doi: 10.3390/jcm9051528. Jean-Hugues Salmon 1 2, Jean-Guillaume Letarouilly 3, Vincent Goëb 4, Lukshe Kanagaratnam 1 5, Pascal Coquerelle 6, Marie-Hélène Guyot 7, Eric Houvenagel 8, Nicolas Lecuyer 9, Laurent Marguerie 10, Gauthier Morel 11, Guy Baudens 12, Elisabeth Gervais 13, René-Marc Flipo 3 Free article |
| 183 | |
A Mixed Methods Evaluation of an Individualised Yoga Therapy Intervention for Rheumatoid Arthritis: Pilot Study |
Complement Ther Med. 2020 May;50:102339.doi: 10.1016/j.ctim.2020.102339.Epub 2020 Feb 6. Tina Cartwright 1, Margaret Cahill 1, Vidhi Sadana 2 Affiliations collapseAffiliations |
| 184 | |
Prevalence of COVID-19 Among Patients With Chronic Inflammatory Rheumatic Diseases Treated With Biologic Agents or Small Molecules: A Population-Based Study in the First Two Months of COVID-19 Outbreak in Italy |
Joint Bone Spine. 2020 May 20;S1297-319X(20)30088-9. doi: 10.1016/j.jbspin.2020.05.003.Online ahead of print. Luca Quartuccio 1, Francesca Valent 2, Enrico Pasut 3, Carlo Tascini 4, Salvatore De Vita 5 |
| 185 | |
Disease Activity and Patient-Reported Outcomes in Patients With Rheumatoid Arthritis and Sjögren |
Rheumatol Int. 2020 May 24. doi: 10.1007/s00296-020-04602-8. Online ahead of print. Leslie R Harrold 1 2, Ying Shan 3, Sabrina Rebello 3, Neil Kramer 4, Sean E Connolly 5, Evo Alemao 5, Sheila Kelly 5, Joel M Kremer 6, Elliot D Rosenstein 4 |
| 186 | |
Modifiable Lifestyle Factors Associated With Response to Treatment in Early Rheumatoid Arthritis |
CR Open Rheumatol. 2020 May 26. doi: 10.1002/acr2.11132. Online ahead of print. Zoe Brown 1, Robert Metcalf 1, Jana Bednarz 2, Llewellyn Spargo 1, Anita Lee 1, Catherine Hill 3, Mihir Wechalekar 4, Christiana Stavrou 5, Michael James 1, Les Cleland 3, Susanna Proudman 3 |
| 187 | |
Tranexamic Acid Does Not Reduce the Risk of Transfusion in Rheumatoid Arthritis Patients Undergoing Total Joint Arthroplasty |
Arthroplasty. 2020 Apr 18;S0883-5403(20)30383-1.doi: 10.1016/j.arth.2020.04.029.Online ahead of print. Kyle W Morse 1, Nicole K Heinz 1, Jeremy M Abolade 1, Joshua I Wright-Chisem 1, Linda A Russell 2, Meng Zhang 3, Serene Z Mirza 2, Dana E Orange 4, Mark P Figgie 1, Peter K Sculco 1, Susan M Goodman 2 |
| 188 | |
Comparison of Infection-Related Hospitalization Risk and Costs in Tumor Necrosis Factor Inhibitor-Experienced Patients With Rheumatoid Arthritis (RA) Treated With Abatacept or Other Targeted Disease-Modifying Anti-Rheumatic Drugs (tDMARDs) |
Med Econ. 2020 May 19;1. doi: 10.1080/13696998.2020.1772271. Online ahead of print. Damemarie Paul 1, Dhaval Patil 1, Laura McDonald 1, Vardhaman Patel 1, Francis Lobo 1 |
| 189 | |
CD28 - Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status |
Front Med (Lausanne). 2020 May 5;7:129. doi: 10.3389/fmed.2020.00129. eCollection 2020. Charlotte Thompson 1 2, Ruth Davies 1, Anwen Williams 1, Gareth Jones 1 3, Ernest H S Choy 1 |
| 190 | |
Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases: A Systematic Review and Meta-analysis |
JAMA Dermatol. 2020 May 20;e201300. doi: 10.1001/jamadermatol.2020.1300.Online ahead of print. Shamarke Esse 1 2, Kayleigh J Mason 2, Adele C Green 2 3 4, Richard B Warren 2 |
| 191 | |
Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate |
Rheumatol. 2020 May 18. doi: 10.1002/art.41316. Online ahead of print. Michael F Robinson 1, Nemanja Damjanov 2, Bojana Stamenkovic 3, Goran Radunovic 2, Alan Kivitz 4, Lori Cox 5, Zorayr Manukyan 6, Christopher Banfield 6, Michael Saunders 6, Deepa Chandra 5, Michael S Vincent 5, Jessica Mancuso 7, Elena Peeva 5, Jean S Beebe 5 |
| 192 | |
Chronic Diarrhoea and Risk of Rheumatoid Arthritis: Findings From the French E3N-EPIC Cohort Study |
Rheumatology (Oxford). 2020 May 17;keaa133. doi: 10.1093/rheumatology/keaa133.Online ahead of print. Yann Nguyen 1 2, Xavier Mariette 3 4, Carine Salliot 1 5, Gaëlle Gusto 1 6, Marie-Christine Boutron-Ruault 1 6, Raphaèle Seror 3 4 |
| 193 | |
Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? |
Neuroimmune Pharmacol. 2020 May 15;1-7. doi: 10.1007/s11481-020-09923-w.Online ahead of print. Priyanka Pahan 1, Kalipada Pahan 2 3 |
| 194 | |
Temporary Interruption of Baricitinib: Characterization of Interruptions and Effect on Clinical Outcomes in Patients With Rheumatoid Arthritis |
Paul Emery 1, Yoshiya Tanaka 2, Tracy Cardillo 3, Douglas Schlichting 3, Terence Rooney 3, Scott Beattie 3, Cameron Helt 3, Josef S Smolen 4 |
| 195 | |
Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center |
ACR Open Rheumatol. 2020 May 15. doi: 10.1002/acr2.11150. Online ahead of print. Emma Stevens 1, Michael E Weinblatt 1, Elena Massarotti 1, Frances Griffin 1, Srinivas Emani 2, Sonali Desai 1 |
| 196 | |
Anxiety and Depression in Reproductive Age Women With Rheumatic Diseases |
Rheumatol Int. 2020 May 5. doi: 10.1007/s00296-020-04591-8. Online ahead of print. Cassandra Michele Skinner-Taylor 1, Lorena Perez-Barbosa 2, Maria Eugenia Corral-Trujillo 1, Itzel Perez-Onofre 1, Eugenio Salvador Barriga-Maldonado 1, Jesus Alberto Cardenas-de la Garza 1, Janett Riega-Torres 1, Dionicio Angel Galarza-Delgado 1 |
| 197 | |
Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient-Reported Outcomes Measurement Information System Pain Interference Short Form in Rheumatoid Arthritis |
ACR Open Rheumatol. 2020 May 9.doi: 10.1002/acr2.11141. Online ahead of print. Patricia Katz 1, Carol L Kannowski 2, Luna Sun 2, Kaleb Michaud 3 |
| 198 | |
Adalimumab Dose Tapering in Patients With Rheumatoid Arthritis Who Are in Long-Standing Clinical Remission: Results of the Phase IV PREDICTRA Study |
Ann Rheum Dis. 2020 May 13;annrheumdis-2020-217246.doi: 10.1136/annrheumdis-2020-217246. Online ahead of print. Paul Emery 1 2, Gerd R Burmester 3, Esperanza Naredo 4, Luigi Sinigaglia 5, Ivan Lagunes 6, Franziska Koenigsbauer 7, Philip G Conaghan 8 2 |
| 199 | |
Rheumatoid Meningitis: Clinical Characteristics, Diagnostic Evaluation, and Treatment |
Neurohospitalist. 2020 Apr;10(2):88-94.doi: 10.1177/1941874419859769. Epub 2019 Jun 30. Angela M Parsons 1, Fawad Aslam 2, Marie F Grill 1, Allen J Aksamit 3, Brent P Goodman 1 |
| 200 | |
Real-World Outcomes Associated With Triple Therapy Versus TNFi/MTX Therapy |
Arthritis Care Res (Hoboken). 2020 May 6. doi: 10.1002/acr.24253. Online ahead of print. Jeffrey R Curtis 1, J Lynn Palmer 2, George W Reed 3, Jeffrey Greenberg 4, Dimitrios A Pappas 5, Leslie R Harrold 3, Joel M Kremer 4 |
| 201 | |
Rheumatology Is Exiting the Age of "Can We" (We Certainly Can) and Now Must Entertain the Question "Should We"? |
Arthritis Care Res (Hoboken). 2020 May 6. doi: 10.1002/acr.24247. Online ahead of print. Bruce Rothschild 1 |
| 202 | |
Management of Fatigue in Rheumatoid Arthritis |
MD Open. 2020 May;6(1):e001084. doi: 10.1136/rmdopen-2019-001084. Janet E Pope 1 |
| 203 | |
Collaboration in Hand Surgery: Experiences From Silicone Arthroplasty in Rheumatoid Arthritis, Finger Replantation and Amputation Challenges in Assessing Impairment, Satisfaction, and Effectiveness, Wrist and Radius Injury Surgical Trial, and Surgery of the Ulnar Nerve |
J Am Acad Orthop Surg. 2020 Apr 27. doi: 10.5435/JAAOS-D-20-00102. Online ahead of print. Robert L Kane 1, Kevin C Chung |
| 204 | |
High Serum Interleukin-6 Is Associated With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis |
Arthritis Rheumatol. 2020 Apr 28. doi: 10.1002/art.41299. Online ahead of print. Anita Boyapati 1, Sergio Schwartzman 2, Jérôme Msihid 3, Ernest Choy 4, Mark C Genovese 5, Gerd R Burmester 6, Gordon Lam 7, Toshio Kimura 1, Jonathan Sadeh 8 9, David M Weinreich 1, George D Yancopoulos 1, Neil M H Graham 1 |
| 205 | |
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study |
J Clin Med. 2020 Apr 24;9(4):E1227.doi: 10.3390/jcm9041227. Maria Antonietta Barbieri 1, Giuseppe Cicala 1, Paola Maria Cutroneo 2, Elisabetta Gerratana 1, Caterina Palleria 3, Caterina De Sarro 3, Ada Vero 3, Luigi Iannone 3, Antonia Manti 3, Emilio Russo 3, Giovambattista De Sarro 3, Fabiola Atzeni 1, Edoardo Spina 1 |
| 206 | |
Tapering of Biological Antirheumatic Drugs in Rheumatoid Arthritis Patients Is Achievable and Cost-Effective in Daily Clinical Practice: Data From the Brussels UCLouvain RA Cohort |
Arthritis Res Ther. 2020 Apr 28;22(1):96.doi: 10.1186/s13075-020-02165-4. Stéphanie Dierckx 1, Tatiana Sokolova 1, Bernard R Lauwerys 1, Aleksandra Avramovska 1, Laurent Meric de Bellefon 1, Adrien Nzeusseu Toukap 1, Maria Stoenoiu 1, Frédéric A Houssiau 1, Patrick Durez 2 |
| 207 | |
Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series |
J Clin Rheumatol. 2020 Apr 25. doi: 10.1097/RHU.0000000000001370. Online ahead of print. Nilasha Ghosh 1 2, Michael D Tiongson 3, Carolyn Stewart 2, Karmela K Chan 1 2, Bridget Jivanelli 1, Laura Cappelli 4, Anne R Bass 1 2 |
| 208 | |
The Microbiome in Rheumatology: Where Are We and Where Should We Go? |
Rheum Dis. 2020 Apr 24;annrheumdis-2019-216631.doi: 10.1136/annrheumdis-2019-216631. Online ahead of print. Julia Manasson 1, Rebecca B Blank 1, Jose U Scher 2 |
| 209 | |
Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019 |
JAMA Netw Open. 2020 Apr 1;3(4):e203969. doi: 10.1001/jamanetworkopen.2020.3969. Alexandra Erath 1, Stacie B Dusetzina 2 |
| 210 | |
Precision Medicine With Leflunomide: Consideration of DHODH Haplotype and Plasma Teriflunomide Concentration Can Substantially Modify Outcomes in Patients With Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2020 Apr 27. doi: 10.1002/acr.24236. Online ahead of print. Michael D Wiese 1 2, Ashley M Hopkins 3, Catherine King 1 4, Mihir D Wechalekar 3 5, Anita Lee 6 7, Llewellyn Spargo 6, Robert Metcalf 6, Leah McWilliams 6, Catherine Hill 6 7 8, Leslie G Cleland 6, Susanna M Proudman 6 7 Affiliations collapse |
| 211 | |
A Qualitative Metasynthesis of the Experience of Fatigue Across Five Chronic Conditions |
Pain Symptom Manage. 2019 Dec 20;S0885-3924(19)31063-2. doi: 10.1016/j.jpainsymman.2019.12.358. Online ahead of print. Rosario B Jaime-Lara 1, Brittany C Koons 2, Lea Ann Matura 2, Nancy A Hodgson 2, Barbara Riegel 2 |
| 212 | |
The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients With Rheumatoid Arthritis: Results From a Prospective Cohort Study |
Nancy A Shadick 1, Patricia Katz 2, Christine I Iannaccone 1, Gabriela Maica 1, Jonathan Coblyn 1, Michael E Weinblatt 1, Jing Cui 1 ACR Open Rheumatol. 2019 Oct 24;1(10):620-626. doi: 10.1002/acr2.11088.eCollection 2019 Dec. |
| 213 | |
Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis |
ACR Open Rheumatol. 2019 Oct 26;1(10):627-631. doi: 10.1002/acr2.11083.eCollection 2019 Dec. Michael D Richter 1, Eric L Matteson 1, John M Davis 3rd 1, Sara J Achenbach 1, Cynthia S Crowson 1 |
| 214 | |
Effectiveness and Safety Over 3 Years After the 2-year U-Act-Early Trial of the Strategies Initiating Tocilizumab and/or Methotrexate |
Rheumatology (Oxford). 2019 Dec 20;kez602. doi: 10.1093/rheumatology/kez602.Online ahead of print. Maxime M A Verhoeven 1, Janneke Tekstra 1, Paco M J Welsing 1, Attila Pethö-Schramm 2, Michelle E A Borm 3, George A W Bruyn 4, Reinhard Bos 5, Ed N Griep 6, Ruth Klaasen 7, Jacob M van Laar 1, Floris P J G Lafeber 1, Johannes W J Bijlsma 1, Marjolein J H de Hair 1, Johannes W G Jacobs 1 |
| 215 | |
Association of Patient, Prescriber, and Region With the Initiation of First Prescription of Biologic Disease-Modifying Antirheumatic Drug Among Older Patients With Rheumatoid Arthritis and Identical Health Insurance Coverage |
Tatangelo M1,2, Tomlinson G1,2, Paterson JM1,3, Ahluwalia V4, Kopp A3, Gomes T1,3,5, Bansback N6, Bombardier C1,2. JAMA Netw Open. 2019 Dec 2;2(12):e1917053. doi: 10.1001/jamanetworkopen.2019.17053. |
| 216 | |
The roles of post-diagnosis accumulation of morbidities and lifestyle changes on excess total and cause-specific mortality risk in rheumatoid arthritis |
Yoshida K1,2, Lin TC1, Wei M3, Malspeis S1, Chu SH1,2,4, Camargo CA2,4,5, Raby BA2,6,7, Choi HK2,8, Tedeschi SK1,2, Barbhaiya M9,10, Lu B1,2, Costenbader KH1,2, Karlson EW1,2, Sparks JA1,2. Arthritis Care Res (Hoboken). 2019 Dec 7. doi: 10.1002/acr.24120. [Epub ahead of print] |
| 217 | |
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study |
Strand V1, van der Heijde D2, Tanaka Y3, Keystone E4, Kremer J5, Zerbini CAF6, Cardiel MH7, Cohen S8, Nash P9, Song YW10, Tegzová D11, Gruben D12, Wallenstein G13, Connell CA12, Fleischmann R8; ORAL Scan investigators. Clin Exp Rheumatol. 2019 Dec 19. [Epub ahead of print] |
| 218 | |
Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication |
Mohamed MF1, Klünder B2, Othman AA3. Clin Pharmacokinet. 2019 Dec 23. doi: 10.1007/s40262-019-00855-0. [Epub ahead of print] |
| 219 | |
Artificial intelligence in detecting early RA |
Stoel BC1. Semin Arthritis Rheum. 2019 Dec;49(3S):S25-S28. doi: 10.1016/j.semarthrit.2019.09.020. |
| 220 | |
Origins of rheumatoid arthritis |
Boissier MC1, Biton J2, Semerano L3, Decker P2, Bessis N2. Joint Bone Spine. 2019 Dec 5. pii: S1297-319X(19)30175-7. doi: 10.1016/j.jbspin.2019.11.009. [Epub ahead of print] |
| 221 | |
Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials |
Keystone EC1, Ahmad HA2, Yazici Y3, Bergman MJ4. Rheumatology (Oxford). 2019 Dec 9. pii: kez455. doi: 10.1093/rheumatology/kez455. [Epub ahead of print] |
| 222 | |
Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae |
McWilliams DF1,2,3, Rahman S1,2,3, James RJE1,4, Ferguson E1,3,4, Kiely PDW5, Young A6, Walsh DA1,2,3,7. BMC Rheumatol. 2019 Nov 18;3:49. doi: 10.1186/s41927-019-0100-9. eCollection 2019. |
| 223 | |
A quarter of patients time their early rheumatoid arthritis onset differently than physicians |
Ellingwood L1, Kudaeva F1, Schieir O2, Bartlett SJ3,4, Bessette L5, Boire G6, Hazlewood GS7, Hitchon C8, Keystone E9, Tin D10, Thorne C11, Bykerk VP12,13, Pope J1; CATCH Investigators. RMD Open. 2019 Nov 14;5(2):e000931. doi: 10.1136/rmdopen-2019-000931. eCollection 2019. |
| 224 | |
Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis |
Curtis JR1, Xie F2, Kay J3, Kallich JD4. Arthritis Res Ther. 2019 Dec 12;21(1):285. doi: 10.1186/s13075-019-2022-8. |
| 225 | |
Insulin Resistant Pathways are associated with Disease Activity in Rheumatoid Arthritis and are Subject to Disease Modification through Metabolic Reprogramming; A Potential Novel Therapeutic Approach |
Gallagher L1,2, Cregan S1, Biniecka M3, Cunningham C2, Veale DJ3, Kane DJ1, Fearon U2, Mullan RH1. Arthritis Rheumatol. 2019 Dec 16. doi: 10.1002/art.41190. [Epub ahead of print] |
| 226 | |
Low Muscle Density is Associated with Deteriorations in Muscle Strength and Physical Functioning in Rheumatoid Arthritis |
Baker JF1,2,3, Mostoufi-Moab S4, Long J5, Taratuta E6, Leonard MB5, Zemel B4. Arthritis Care Res (Hoboken). 2019 Dec 16. doi: 10.1002/acr.24126. [Epub ahead of print] |
| 227 | |
Obstructive lung diseases and risk of rheumatoid arthritis |
Friedlander HM1, Ford JA1,2, Zaccardelli A1, Terrio AV1, Cho MH2,3,4, Sparks JA1,2. Expert Rev Clin Immunol. 2020 Jan;16(1):37-50. doi: 10.1080/1744666X.2019.1698293. Epub 2020 Jan 6. |
| 228 | |
Rheumatoid arthritis and risk of spontaneous abortion: a Danish nationwide cohort study |
Nathan NO1,2, Mørch LS2, Wu CS3,4, Olsen J5,6, Hetland ML7,8, Li J5, Rom AL1,2. Rheumatology (Oxford). 2019 Nov 27. pii: kez565. doi: 10.1093/rheumatology/kez565. [Epub ahead of print] |
| 229 | |
Patient Perspectives on Switching from Infliximab to Infliximab-dyyb in Patients with Rheumatologic Diseases in the United States |
Chau J1, Delate T2, Ota T2, Bhardwaja B3. ACR Open Rheumatol. 2019 Mar 15;1(1):52-57. doi: 10.1002/acr2.1007. eCollection 2019 Mar. |
| 230 | |
The Self-Administered Rheumatoid Arthritis Disease Activity Index (RADAI) is Less Accurate than DAS28-CRP as a Disease Activity Measure in Pregnancy |
Smeele HTW1, Naterop J1, Röder E1, Hazes JMW1, Dolhain RJEM1. ACR Open Rheumatol. 2019 Mar 30;1(2):97-103. doi: 10.1002/acr2.1012. eCollection 2019 Apr. |
| 231 | |
Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study |
Cannon GW1,2, Erickson AR3, Teng CC1,4, Huynh T1,4, Austin S1,5, Wade SW6, Stolshek BS7, Collier DH8, Mutebi A7, Sauer BC1,4. Rheumatol Adv Pract. 2019 May 28;3(1):rkz015. doi: 10.1093/rap/rkz015. eCollection 2019. |
| 232 | |
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs |
Strand V1, Schiff M2, Tundia N3, Friedman A4, Meerwein S5, Pangan A4, Ganguli A4, Fuldeore M4, Song Y6, Pope J7. Arthritis Res Ther. 2019 Dec 2;21(1):263. doi: 10.1186/s13075-019-2059-8. |
| 233 | |
Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study |
Yates M1, MacGregor AJ2, Ledingham J3, Norton S4, Bechman K1, Dennison EM5, Galloway JB1. Rheumatology (Oxford). 2019 Dec 5. pii: kez550. doi: 10.1093/rheumatology/kez550. [Epub ahead of print] |
| 234 | |
Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
Strand V1, Pope J2, Tundia N3, Friedman A4, Camp HS4, Pangan A4, Ganguli A4, Fuldeore M4, Goldschmidt D5, Schiff M6. Arthritis Res Ther. 2019 Dec 9;21(1):272. doi: 10.1186/s13075-019-2037-1. |
| 235 | |
Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA |
Hamann PDH1, Pauling JD2, McHugh N2, Hyrich K3,4, Shaddick G5. Rheumatology (Oxford). 2019 Nov 12. pii: kez518. doi: 10.1093/rheumatology/kez518. [Epub ahead of print] |
| 236 | |
Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race |
Roberts MH1, Erdei E2. Autoimmun Rev. 2020 Jan;19(1):102423. doi: 10.1016/j.autrev.2019.102423. Epub 2019 Nov 14. |
| 237 | |
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis |
Burmester GR1, Gordon KB2, Rosenbaum JT3, Arikan D4, Lau WL4, Li P4, Faccin F4, Panaccione R5. Adv Ther. 2020 Jan;37(1):364-380. doi: 10.1007/s12325-019-01145-8. Epub 2019 Nov 20. |
| 238 | |
Reasons for b/tsDMARD cessation and persistence of second line treatment in a large real world rheumatoid arthritis dataset |
Youssef P1, Marcal B1, Button P1, Truman M1, Bird P1, Dip G1, Griffiths H1, Roberts L1, Tymms K1, Littlejohn G1. J Rheumatol. 2019 Dec 1. pii: jrheum.190535. doi: 10.3899/jrheum.190535. [Epub ahead of print] |
| 239 | |
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease |
Inoue D7, Kawano M8, Khosroshahi A9, Lanzillotta M10, Okazaki K11, Perugino CA12, Sharma A13, Saeki T14, Schleinitz N15, Takahashi N16, Umehara H17, Zen Y18, Stone JH19; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. |
| 240 | |
Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians |
Bendstrup E1, Møller J1, Kronborg-White S1, Prior TS1, Hyldgaard C2. J Clin Med. 2019 Nov 21;8(12). pii: E2038. doi: 10.3390/jcm8122038. |
| 241 | |
Retrospective Analysis of the Impact of Adalimumab Initiation on Corticosteroid Utilization and Medical Costs Among Biologic-Naïve Patients with Rheumatoid Arthritis |
Spivey CA1, Winthrop KL2, Griffith J3, Kaplan CM4, Qiao Y1, Postlethwaite AE5, Wang J6. Rheumatol Ther. 2020 Mar;7(1):133-147. doi: 10.1007/s40744-019-00184-5. Epub 2019 Nov 18. |
| 242 | |
Interstitial Lung Disease as the Initial Manifestation of Rheumatoid Arthritis: A Case Report and Review of the Literature |
Singh K1, Al-Sadawi M1, Ortega RR1, Akter K1, Zrodlowski T1, Zmijewski C1, McFarlane IM1. Am J Med Case Rep. 2019;7(12):342-347. doi: 10.12691/ajmcr-7-12-10. Epub 2019 Oct 28. |
| 243 | |
Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis |
Schäfer M1, Meißner Y1, Kekow J2,3, Berger S4, Remstedt S5, Manger B6, Listing J1, Strangfeld A1, Zink A1,7. Rheumatology (Oxford). 2019 Nov 20. pii: kez535. doi: 10.1093/rheumatology/kez535. [Epub ahead of print] |
| 244 | |
Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach |
Feldman CH1, Yoshida K1, Xu C1, Frits ML1, Shadick NA1, Weinblatt ME1, Connolly SE2, Alemao E2, Solomon DH1. ACR Open Rheumatol. 2019 Sep 4;1(9):552-559. doi: 10.1002/acr2.11068. eCollection 2019 Nov. |
| 245 | |
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data |
Emery P1, Furst DE2,3,4, Kirchner P5, Melega S5, Lacey S6, Lehane PB7. |
| 246 | |
Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years |
Pope JE1, Keystone E2, Jamal S3, Wang L4, Fallon L5, Woolcott J5, Lazariciu I6, Chapman D7, Haraoui B8. ACR Open Rheumatol. 2019 Mar 28;1(2):73-82. doi: 10.1002/acr2.1010. eCollection 2019 Apr. |
| 247 | |
Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical Trials |
Simon TA1, Soule BP1, Hochberg M2, Fleming D1, Torbeyns A3, Banerjee S1, Boers M4. ACR Open Rheumatol. 2019 May 29;1(4):251-257. doi: 10.1002/acr2.1034. eCollection 2019 Jun. |
| 248 | |
The Impact of Frailty on Changes in Physical Function and Disease Activity Among Adults With Rheumatoid Arthritis |
Andrews JS1, Trupin L2, Wysham KD3, Hough CL1, Yelin EH2, Katz PP2. ACR Open Rheumatol. 2019 Jul 28;1(6):366-372. doi: 10.1002/acr2.11051. eCollection 2019 Aug. |
| 249 | |
Joint Estimation of Remission and Response for Methotrexate-Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta-Analysis |
Pokharel G1, Deardon R1, Barnabe C1, Bykerk V2, Bartlett SJ3, Bessette L4, Boire G5, Hitchon CA6, Keystone E7, Pope J8, Schieir O7, Tin D9, Thorne C9, Hazlewood GS1; Canadian Early Arthritis Cohort (CATCH) Investigators, Baron M1,2,3,4,5,6,7,8,9, Bessette L1,2,3,4,5,6,7,8,9, Boire G1,2,3,4,5,6,7,8,9, Bykerk V1,2,3,4,5,6,7,8,9, Colmegna I1,2,3,4,5,6,7,8,9, Fallavollita S1,2,3,4,5,6,7,8,9, Haaland D1,2,3,4,5,6,7,8,9, Haraoui P1,2,3,4,5,6,7,8,9, Hazlewood G1,2,3,4,5,6,7,8,9, Hitchon C1,2,3,4,5,6,7,8,9, Jamal S1,2,3,4,5,6,7,8,9, Joshi R1,2,3,4,5,6,7,8,9, Keystone E1,2,3,4,5,6,7,8,9, Nair B1,2,3,4,5,6,7,8,9, Panopoulos P1,2,3,4,5,6,7,8,9, Penney C1,2,3,4,5,6,7,8,9, Pope J1,2,3,4,5,6,7,8,9, Rubin L1,2,3,4,5,6,7,8,9, Thorne C1,2,3,4,5,6,7,8,9, Villeneuve E1,2,3,4,5,6,7,8,9, Zummer M1,2,3,4,5,6,7,8,9. ACR Open Rheumatol. 2019 Aug 8;1(8):471-479. doi: 10.1002/acr2.11052. eCollection 2019 Oct. |
| 250 | |
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis |
Reed GW1,2, Gerber RA3, Shan Y4, Takiya L5, Dandreo KJ4, Gruben D3, Kremer J6, Wallenstein G3. Rheumatol Ther. 2019 Nov 9. doi: 10.1007/s40744-019-00177-4. [Epub ahead of print] |
| 251 | |
Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials |
Smolen J1, Fleischmann R2, Aletaha D3, Li Y4, Zhou Y4, Sainsbury I5, Galindo IL4. Arthritis Res Ther. 2019 Nov 10;21(1):231. doi: 10.1186/s13075-019-2005-9. |
| 252 | |
2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis |
Barber CEH1, Zell J2, Yazdany J3, Davis AM4, Cappelli L5, Ehrlich-Jones L6, Everix D7, Thorne JC8, Bohm V1, Suter L9, Limanni A10, Michaud K11. Arthritis Care Res (Hoboken). 2019 Dec;71(12):1531-1539. doi: 10.1002/acr.24040. Epub 2019 Nov 11. |
| 253 | |
2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures |
England BR1, Tiong BK2, Bergman MJ3, Curtis JR4, Kazi S5, Mikuls TR1, O'Dell JR1, Ranganath VK2, Limanni A6, Suter LG7, Michaud K8. Arthritis Care Res (Hoboken). 2019 Dec;71(12):1540-1555. doi: 10.1002/acr.24042. Epub 2019 Nov 11. |
| 254 | |
An Analysis of Real-World Data on the Safety of Etanercept in Older Patients with Rheumatoid Arthritis |
Edwards CJ1, Bukowski JF2, Burns SM3, Jones HE2, Pedersen R2, Sopczynski J2, Marshall L2. Drugs Aging. 2020 Jan;37(1):35-41. doi: 10.1007/s40266-019-00721-5. |
| 255 | |
The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis |
Peterson S1, Piercy J2,3, Blackburn S2, Sullivan E2, Karyekar CS1, Li N1. BMC Rheumatol. 2019 Oct 28;3:43. doi: 10.1186/s41927-019-0092-5. eCollection 2019. |
| 256 | |
A biopsychosocial network model of fatigue in rheumatoid arthritis: a systematic review |
Geenen R1, Dures E2,3. Rheumatology (Oxford). 2019 Nov 1;58(Supplement_5):v10-v21. doi: 10.1093/rheumatology/kez403. |
| 257 | |
The role of non-pharmacological interventions in the management of rheumatoid-arthritis-related fatigue |
Cramp F1. Rheumatology (Oxford). 2019 Nov 1;58(Supplement_5):v22-v28. doi: 10.1093/rheumatology/kez310. |
| 258 | |
Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study |
Simon TA1, Boers M2, Hochberg M3, Baker N4, Skovron ML4, Ray N5, Singhal S5, Suissa S6, Gomez-Caminero A4. Arthritis Res Ther. 2019 Nov 8;21(1):228. doi: 10.1186/s13075-019-1992-x. |
| 259 | |
Coronary microvascular dysfunction in rheumatoid arthritis compared to diabetes mellitus and association with all-cause mortality |
Liao KP1, Huang J1, He Z1, Cremone G1, Lam E1, Hainer JM2, Morgan V2, Bibbo C2, Di Carli M2,3. Arthritis Care Res (Hoboken). 2019 Nov 9. doi: 10.1002/acr.24108. [Epub ahead of print] |
| 260 | |
Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis |
Walsh JA1, Pei S2, Penmetsa GK1, Sauer BC2, Patil V2, Walker JH3, Clewell J3, Douglas KM3, Clegg DO1, Cannon GW1, Halwani A4. J Manag Care Spec Pharm. 2019 Nov;25(11):1218-1228. doi: 10.18553/jmcp.2019.25.11.1218 |
| 261 | |
Patient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results |
Bartlett SJ1,2, De Leon E2,3, Orbai AM2, Haque UJ2, Manno RL2, Ruffing V2, Butanis A2, Duncan T2, Jones MR2, Leong A4, Perin J5, Smith KC3, Bingham CO2. Rheumatology (Oxford). 2019 Oct 30. pii: kez506. doi: 10.1093/rheumatology/kez506. [Epub ahead of print] |
| 262 | |
Pregnancy and rheumatoid arthritis |
Littlejohn EA1. Best Pract Res Clin Obstet Gynaecol. 2019 Oct 9. pii: S1521-6934(19)30136-1. doi: 10.1016/j.bpobgyn.2019.09.005. [Epub ahead of print] |
| 263 | |
Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension |
Burmester GR1, Strand V2, Rubbert-Roth A3, Amital H4, Raskina T5, Gómez-Centeno A6, Pena-Rossi C7, Gervitz L8, Thangavelu K9, St John G10, Boklage S10, Genovese MC11. RMD Open. 2019 Oct 18;5(2):e001017. doi: 10.1136/rmdopen-2019-001017. eCollection 2019 |
| 264 | |
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial |
Strand V1, Mysler E2, Moots RJ3, Wallenstein GV4, DeMasi R5, Gruben D4, Soma K4, Iikuni N6, Smolen JS7, Fleischmann R8. RMD Open. 2019 Oct 1;5(2):e001040. doi: 10.1136/rmdopen-2019-001040. eCollection 2019 |